Verktøy  

Litteraturliste

  1. Ellekjaer H, Holmen J, Indredavik B, Terent A. Epidemiology of stroke in Innherred, Norway, 1994 to 1996 Incidence and 30-day case-fatality rate. Stroke 1997;28(11):2180-4.

  2. Ellekjaer H, Selmer R. Hjerneslag - like mange rammes, men prognosen er bedre. Tidsskr Nor Lægeforen 2007;127(6):740-3.

  3. Scenario 2030. Sykdomsutvikling for eldre fram til 2030. Oslo: Statens helsetilsyn; 1999.

  4. Fjaertoft H, Indredavik B. Kostnadsvurderinger ved hjerneslag. Tidsskr Nor Lægeforen 2007;127(6):744-7.

  5. Hatano S. Experience from a multicentre stroke register: a preliminary report. Bull World Health Organ 1976;54(5):541-53.

  6. Nasjonale retningslinjer for individuell primærforebygging av hjerte- og karsykdommer. Oslo: Helsedirektoratet; 2009. Tilgjengelig fra: www.helsedirektoratet.no/vp/multimedia/archive/00116/Nasjonale_Retningsl_116709a.pdf

  7. Evaluering av faglige retningslinjer. Agree-instrumentet. Oslo: The Agree Collaboration; Sosial- og helsedirektoratet; 2003.

  8. National stroke foundation. Clinical guidelines for acute stroke management. Australian Government, National Health and Medical Research Council; 2007. Tilgjengelig fra: www.strokefoundation.com.au/component/option,com_docman/Itemid,174/task,doc_download/gid,107/

  9. Bonita R, Solomon N, Broad JB. Prevalence of stroke and stroke-related disability. Estimates from the Auckland stroke studies. Stroke 1997;28(10):1898-902.

  10. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006;367(9524):1747-57.

  11. Kwan J, Sandercock P. In-hospital care pathways for stroke. Cochrane Database Syst Rev 2004;(4):CD002924.

  12. Organised inpatient (stroke unit) care for stroke. Cochrane Database Syst Rev 2007;(4):CD000197.

  13. Langhorne P, Taylor G, Murray G, Dennis M, Anderson C, Bautz-Holter E, et al. Early supported discharge services for stroke patients: a meta-analysis of individual patients’ data. Lancet 2005;365(9458):501-6.

  14. Services for reducing duration of hospital care for acute stroke patients. Cochrane Database Syst Rev 2005;(2):CD000443.

  15. Fjaertoft H, Indredavik B, Magnussen J, Johnsen R. Early supported discharge for stroke patients improves clinical outcome. Does it also reduce use of health services and costs? One-year follow-up of a randomized controlled trial. Cerebrovasc Dis 2005;19(6):376-83.

  16. Hacke W, Donnan G, Fieschi C, Kaste M, von Kummer R, Broderick JP, et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004;363(9411):768-74.

  17. Langhorne P, Pollock A. What are the components of effective stroke unit care? Age Ageing 2002;31(5):365-71.

  18. Wester P, Radberg J, Lundgren B, Peltonen M. Factors associated with delayed admission to hospital and in-hospital delays in acute stroke and TIA: a prospective, multicenter study. Seek- Medical-Attention-in-Time Study Group. Stroke 1999;30(1):40-8.

  19. Kwan J, Hand P, Sandercock P. A systematic review of barriers to delivery of thrombolysis for acute stroke. Age Ageing 2004;33(2):116-21.

  20. Mosley I, Nicol M, Donnan G, Patrick I, Dewey H. Stroke symptoms and the decision to call for an ambulance. Stroke 2007;38(2):361-6.

  21. Lacy CR, Suh DC, Bueno M, Kostis JB. Delay in presentation and evaluation for acute stroke: Stroke Time Registry for Outcomes Knowledge and Epidemiology (S.T.R.O.K.E.). Stroke 2001;32(1):63-9.

  22. Mehdiratta M, Woolfenden AR, Chapman KM, Johnston DC, Schulzer M, Beckman J, et al. Reduction in IV t-PA door to needle times using an Acute Stroke Triage Pathway. Can J Neurol Sci 2006;33(2):214-6.

  23. Indredavik B. En effektiv slagenhet - hva er det? Tidsskr Nor Lægeforen 2007;127(9):1214-8.

  24. Indredavik B, Bakke F, Slordahl SA, Rokseth R, Haheim LL. Stroke unit treatment. 10-year follow-up. Stroke 1999;30(8):1524-7.

  25. Seenan P, Long M, Langhorne P. Stroke units in their natural habitat: systematic review of observational studies. Stroke 2007;38(6):1886-92.

  26. Aboderin I, Venables G. Stroke management in Europe. Pan European Consensus Meeting on Stroke Management. J Intern Med 1996;240(4):173-80.

  27. Nationella riktlinjer for strokesjukvård: medicinskt och hälsoekonomiskt faktadokument. Stockholm: Socialstyrelsen ; 2005. Tilgjengelig fra: www.socialstyrelsen.se/NR/rdonlyres/B9011B06-2FF8-4AA2-99C8-65C725C6CC76/4864/_20061021.pdf

  28. Coull AJ, Lovett JK, Rothwell PM. Population based study of early risk of stroke after transient ischaemic attack or minor stroke: implications for public education and organisation of services. BMJ 2004;328(7435):326.

  29. Giles MF, Rothwell PM. Risk of stroke early after transient ischaemic attack: a systematic review and meta-analysis. Lancet Neurol 2007;6(12):1063-72.

  30. Rothwell PM, Giles MF, Chandratheva A, Marquardt L, Geraghty O, Redgrave JN, et al. Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparison. Lancet 2007;370(9596):1432-42.

  31. Outpatient Service Trialist. Therapy-based rehabilitation services for stroke patients at home. Cochrane Database Syst Rev 2003;(1):CD002925.

  32. Fjaertoft H, Indredavik B, Lydersen S. Stroke unit care combined with early supported discharge: long-term follow-up of a randomized controlled trial. Stroke 2003;34(11):2687-91.

  33. Morris DL, Rosamond W, Madden K, Schultz C, Hamilton S. Prehospital and emergency department delays after acute stroke: the Genentech Stroke Presentation Survey. Stroke 2000;31(11):2585-90.

  34. Agyeman O, Nedeltchev K, Arnold M, Fischer U, Remonda L, Isenegger J, et al. Time to admission in acute ischemic stroke and transient ischemic attack. Stroke 2006;37(4):963-6.

  35. Harbison J, Hossain O, Jenkinson D, Davis J, Louw SJ, Ford GA. Diagnostic accuracy of stroke referrals from primary care, emergency room physicians, and ambulance staff using the face arm speech test. Stroke 2003;34(1):71-6.

  36. Diez-Tejedor E, Fuentes B. Acute care in stroke: the importance of early intervention to achieve better brain protection. Cerebrovasc Dis 2004;17 Suppl 1:130-7.

  37. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995;333(24):1581-7.

  38. Steiner T, Bluhmki E, Kaste M, Toni D, Trouillas P, von Kummer R, et al. The ECASS 3-hour cohort. Secondary analysis of ECASS data by time stratification. ECASS Study Group. European Cooperative Acute Stroke Study. Cerebrovasc Dis 1998;8(4): 198-203.160

  39. Lindsberg PJ, Happola O, Kallela M, Valanne L, Kuisma M, Kaste M. Door to thrombolysis: ER reorganization and reduced delays to acute stroke treatment. Neurology 2006;67(2):334-6.

  40. Nor AM, Davis J, Sen B, Shipsey D, Louw SJ, Dyker AG, et al. The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument. Lancet Neurol 2005;4(11):727-34.

  41. Goldstein LB, Samsa GP. Reliability of the National Institutes of Health Stroke Scale. Extension to non-neurologists in the context of a clinical trial. Stroke 1997;28(2):307-10.

  42. Morgenstern LB, Lisabeth LD, Mecozzi AC, Smith MA, Longwell PJ, McFarling DA, et al. A population-based study of acute stroke and TIA diagnosis. Neurology 2004;62(6):895-900.

  43. von Kummer R, Bourquain H, Bastianello S, Bozzao L, Manelfe C, Meier D, et al. Early prediction of irreversible brain damage after ischemic stroke at CT. Radiology 2001;219(1):95-100.

  44. von Kummer R, Nolte PN, Schnittger H, Thron A, Ringelstein EB. Detectability of cerebral hemisphere ischaemic infarcts by CT within 6 h of stroke. Neuroradiology 1996;38(1):31-3.

  45. von Kummer R, Allen KL, Holle R, Bozzao L, Bastianello S, Manelfe C, et al. Acute stroke: usefulness of early CT findings before thrombolytic therapy. Radiology 1997;205(2):327-33.

  46. Mullins ME, Schaefer PW, Sorensen AG, Halpern EF, Ay H, He J, et al. CT and conventional and diffusion-weighted MR imaging in acute stroke: study in 691 patients at presentation to the emergency department. Radiology 2002;224(2):353-60.

  47. Tomsick T, Brott T, Barsan W, Broderick J, Haley EC, Spilker J, et al. Prognostic value of the hyperdense middle cerebral artery sign and stroke scale score before ultraearly thrombolytic therapy. AJNR Am J Neuroradiol 1996;17(1):79-85.

  48. Barber PA, Demchuk AM, Hudon ME, Pexman JH, Hill MD, Buchan AM. Hyperdense sylvian fissure MCA “dot” sign: a CT marker of acute ischemia. Stroke 2001;32(1):84-8.

  49. Brott T, Broderick J, Kothari R, Barsan W, Tomsick T, Sauerbeck L, et al. Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke 1997;28(1):1-5.

  50. Jauch EC, Lindsell CJ, Adeoye O, Khoury J, Barsan W, Broderick J, et al. Lack of evidence for an association between hemodynamic variables and hematoma growth in spontaneous intracerebral hemorrhage. Stroke 2006;37(8):2061-5.

  51. Masdeu JC, Irimia P, Asenbaum S, Bogousslavsky J, Brainin M, Chabriat H, et al. EFNS guideline on neuroimaging in acute stroke. Report of an EFNS task force. Eur J Neurol 2006;13(12):1271-83.

  52. Neumann-Haefelin T, du Mesnil dR, Fiebach JB, Gass A, Nolte C, Kucinski T, et al. Effect of incomplete (spontaneous and postthrombolytic) recanalization after middle cerebral artery occlusion: a magnetic resonance imaging study. Stroke 2004;35(1):109-14.

  53. Adams HP, Jr., del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 2007;38(5):1655-711.

  54. Jaillard A, Hommel M, Baird AE, Linfante I, Llinas RH, Caplan LR, et al. Significance of early CT signs in acute stroke. A CT scan-diffusion MRI study. Cerebrovasc Dis 2002;13(1):47-56.

  55. Baird AE, Dashe J, Connor A, Burzynski C, Schlaug G, Warach S. Comparison of retrospective and prospective measurements of the national institutes of health stroke scale. Cerebrovasc Dis 2000;10(1):80-1.

  56. Baird AE, Benfield A, Schlaug G, Siewert B, Lovblad KO, Edelman RR, et al. Enlargement of human cerebral ischemic lesion volumes measured by diffusion-weighted magnetic resonance imaging. Ann Neurol 1997;41(5):581-9.

  57. Schellinger PD, Richter G, Kohrmann M, Dorfler A. Noninvasive angiography (magnetic resonance and computed tomography) in the diagnosis of ischemic cerebrovascular disease. Techniques and clinical applications. Cerebrovasc Dis 2007;24 Suppl 1:16-23.

  58. Verro P, Tanenbaum LN, Borden N, Eshkar N, Sen S. Clinical application of CT angiography in acute ischemic stroke. Clin Neurol Neurosurg 2007;109(2):138-45.

  59. Wardlaw JM, Chappell FM, Best JJ, Wartolowska K, Berry E. Non-invasive imaging compared with intra-arterial angiography in the diagnosis of symptomatic carotid stenosis: a meta-analysis. Lancet 2006;367(9521):1503-12.

  60. Wintermark M, Reichhart M, Thiran JP, Maeder P, Chalaron M, Schnyder P, et al. Prognostic accuracy of cerebral blood flow measurement by perfusion computed tomography, at the time of emergency room admission, in acute stroke patients. Ann Neurol 2002;51(4):417-32.

  61. Hennerici M, Baezner H, Daffertshofer M. Ultrasound and arterial wall disease. Cerebrovasc Dis 2004;17 Suppl 1:19-33.

  62. Chernyshev OY, Garami Z, Calleja S, Song J, Campbell MS, Noser EA, et al. Yield and accuracy of urgent combined carotid/transcranial ultrasound testing in acute cerebral ischemia. Stroke 2005;36(1):32-7.

  63. Alexandrov AV, Demchuk AM, Wein TH, Grotta JC. Yield of transcranial Doppler in acute cerebral ischemia. Stroke 1999;30(8):1604-9.

  64. Postert T, Braun B, Meves S, Koster O, Przuntek H, Weber S, et al. Contrast-enhanced transcranial color-coded sonography in acute hemispheric brain infarction. Stroke 1999;30(9):1819-26

  65. Alexandrov AV, Wojner AW, Grotta JC. CLOTBUST: design of a randomized trial of ultrasound-enhanced thrombolysis for acute ischemic stroke. J Neuroimaging 2004;14(2):108-12.

  66. Christou I, Alexandrov AV, Burgin WS, Wojner AW, Felberg RA, Malkoff M, et al. Timing of recanalization after tissue plasminogen activator therapy determined by transcranial doppler correlates with clinical recovery from ischemic stroke. Stroke 2000;31(8):1812-6.

  67. Thomassen L, Waje-Andreassen U, Naess H, Aarseth J, Russell D. Doppler ultrasound and clinical findings in patients with acute ischemic stroke treated with intravenous thrombolysis. Eur J Neurol 2005;12(6):462-5.

  68. Serena J, Segura T, Castellanos M, Davalos A. Microembolic signal monitoring in hemispheric acute ischaemic stroke: a prospective study. Cerebrovasc Dis 2000;10(4):278-82.

  69. Lund C, Rygh J, Stensrod B, Sandset PM, Brucher R, Russell D. Cerebral microembolus detection in an unselected acute ischemic stroke population. Cerebrovasc Dis 2000;10(5):403-8.

  70. Markus HS, Thomson ND, Brown MM. Asymptomatic cerebral embolic signals in symptomatic and asymptomatic carotid artery disease. Brain 1995;118(Pt 4):1005-11.

  71. Mackinnon AD, Aaslid R, Markus HS. Ambulatory transcranial Doppler cerebral embolic signal detection in symptomatic and asymptomatic carotid stenosis. Stroke 2005;36(8):1726-30.

  72. Markus HS, Droste DW, Kaps M, Larrue V, Lees KR, Siebler M, et al. Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using doppler embolic signal detection: the Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) trial. Circulation 2005;111(17):2233-40.

  73. Sloan MA, Alexandrov AV, Tegeler CH, Spencer MP, Caplan LR, Feldmann E, et al. Assessment: transcranial Doppler ultrasonography: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2004;62(9):1468-81.

  74. Hacke W, Kaste M, Bluhmki E, Brozman M, Davalos A, Guidetti D, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008;359(13):1317-29.162

  75. Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 1995;274(13):1017-25.

  76. Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet 1998;352(9136):1245-51.

  77. Clark WM, Wissman S, Albers GW, Jhamandas JH, Madden KP, Hamilton S. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. JAMA 1999;282(21):2019-26.

  78. Wahlgren N, Ahmed N, Davalos A, Ford GA, Grond M, Hacke W, et al. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet 2007;369(9558):275-82.

  79. Wahlgren N, Ahmed N, Davalos A, Hacke W, Millan M, Muir K, et al. Thrombolysis with alteplase 3-4.5 h after acute ischaemic stroke (SITS-ISTR): an observational study. Lancet 2008;372(9646):1303-9.

  80. Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 1999;282(21):2003-11.

  81. Flaherty ML, Woo D, Kissela B, Jauch E, Pancioli A, Carrozzella J, et al. Combined IV and intra-arterial thrombolysis for acute ischemic stroke. Neurology 2005;64(2):386-8.

  82. Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study. Stroke 2004;35(4):904-11.

  83. Schellinger PD, Hacke W. Intra-arterial thrombolysis is the treatment of choice for basilar thrombosis: pro. Stroke 2006;37(9):2436-7.

  84. Smith WS. Intra-arterial thrombolytic therapy for acute basilar occlusion: pro. Stroke 2007;38(2 Suppl):701-3.

  85. Arnold M, Nedeltchev K, Schroth G, Baumgartner RW, Remonda L, Loher TJ, et al. Clinical and radiological predictors of recanalisation and outcome of 40 patients with acute basilar artery occlusion treated with intra-arterial thrombolysis. J Neurol Neurosurg Psychiatry 2004;75(6):857-62.

  86. Katz JM, Gobin YP, Segal AZ, Riina HA. Mechanical embolectomy. Neurosurg Clin N Am 2005;16(3):463-74, v.

  87. Smith WS, Sung G, Starkman S, Saver JL, Kidwell CS, Gobin YP, et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 2005;36(7):1432-8.

  88. Choi JH, Bateman BT, Mangla S, Marshall RS, Prabhakaran S, Chong J, et al. Endovascular recanalization therapy in acute ischemic stroke. Stroke 2006;37(2):419-24.

  89. Stead LG, Gilmore RM, Bellolio MF, Rabinstein AA, Decker WW. Percutaneous clot removal devices in acute ischemic stroke: a systematic review and meta-analysis. Arch Neurol 2008;65(8):1024-30.

  90. Smith WS, Sung G, Saver J, Budzik R, Duckwiler G, Liebeskind DS, et al. Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke 2008;39(4):1205-12.

  91. Mandava P, Kent TA. Intra-arterial therapies for acute ischemic stroke. Neurology 2007;68(24):2132-9.

  92. Qureshi AI, Suarez JI, Yahia AM, Mohammad Y, Uzun G, Suri MF, et al. Timing of neurologic deterioration in massive middle cerebral artery infarction: a multicenter review. Crit Care Med 2003;31(1):272-7.

  93. Bereczki D, Liu M, do Prado GF, Fekete I. Mannitol for acute stroke. Cochrane Database Syst Rev 2001;(1):CD001153.

  94. Righetti E, Celani MG, Cantisani TA, Sterzi R, Boysen G, Ricci S. Glycerol for acute stroke: a Cochrane systematic review. J Neurol 2002;249(4):445-51.

  95. Gupta R, Connolly ES, Mayer S, Elkind MS. Hemicraniectomy for massive middle cerebral artery territory infarction: a systematic review. Stroke 2004;35(2):539-43.

  96. Hofmeijer J, van der Worp HB, Kappelle LJ. Treatment of space-occupying cerebral infarction. Crit Care Med 2003;31(2):617-25.

  97. Vahedi K, Hofmeijer J, Juettler E, Vicaut E, George B, Algra A, et al. Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials. Lancet Neurol 2007;6(3):215-22.

  98. Jauss M, Krieger D, Hornig C, Schramm J, Busse O. Surgical and medical management of patients with massive cerebellar infarctions: results of the German-Austrian Cerebellar Infarction Study. J Neurol 1999;246(4):257-64.

  99. Chen CC, Cho DY, Tsai SC. Outcome of and prognostic factors for decompressive hemicraniectomy in malignant middle cerebral artery infarction. J Clin Neurosci 2007;14(4):317-21.

  100. Sandercock P, Gubitz G, Foley P, Counsell C. Antiplatelet therapy for acute ischaemic stroke. Cochrane Database Syst Rev 2003;(2):CD000029.

  101. Chen ZM, Sandercock P, Pan HC, Counsell C, Collins R, Liu LS, et al. Indications for early aspirin use in acute ischemic stroke: a combined analysis of 40 000 randomized patients from the chinese acute stroke trial and the international stroke trial. On behalf of the CAST and IST collaborative groups. Stroke 2000;31(6):1240-9.

  102. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group. Lancet 1997;349(9065):1569-81.

  103. CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. CAST (Chinese Acute Stroke Trial) Collaborative Group. Lancet 1997;349(9066):1641-9.

  104. Gubitz G, Sandercock P, Counsell C. Anticoagulants for acute ischaemic stroke. Cochrane Database Syst Rev 2004;(3):CD000024.

  105. Bath PM, Iddenden R, Bath FJ. Low-molecular-weight heparins and heparinoids in acute ischemic stroke: a meta-analysis of randomized controlled trials. Stroke 2000;31(7):1770-8.

  106. Low molecular weight heparinoid, ORG 10172 (danaparoid), and outcome after acute ischemic stroke: a randomized controlled trial. The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. JAMA 1998;279(16):1265-72.

  107. Berge E, Abdelnoor M, Nakstad PH, Sandset PM. Low molecular-weight heparin versus aspirin in patients with acute ischaemic stroke and atrial fibrillation: a double-blind randomised study. HAEST Study Group. Heparin in Acute Embolic Stroke Trial. Lancet 2000;355(9211):1205-10.

  108. Bath PM, Lindenstrom E, Boysen G, De Deyn P, Friis P, Leys D, et al. Tinzaparin in acute ischaemic stroke (TAIST): a randomised aspirin-controlled trial. Lancet 2001;358(9283):702-10.

  109. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. EAFT (European Atrial Fibrillation Trial) Study Group. Lancet 1993;342(8882):1255-62.

  110. Berge E, Sandercock P. Anticoagulants versus antiplatelet agents for acute ischaemic stroke. Cochrane Database Syst Rev 2002;(4):CD003242.

  111. Dennis MS, Bamford JM, Sandercock PA, Warlow CP. Incidence of transient ischemic attacks in Oxfordshire, England. Stroke 1989;20(3):333-9.

  112. Kidwell CS, Alger JR, Di Salle F, Starkman S, Villablanca P, Bentson J, et al. Diffusion MRI in patients with transient ischemic attacks. Stroke 1999;30(6):1174-80.164

  113. Lovett JK, Dennis MS, Sandercock PA, Bamford J, Warlow CP, Rothwell PM. Very early risk of stroke after a first transient ischemic attack. Stroke 2003;34(8):e138-e140.

  114. Johnston SC, Rothwell PM, Nguyen-Huynh MN, Giles MF, Elkins JS, Bernstein AL, et al. Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack. Lancet 2007;369(9558):283-92.

  115. Sciolla R, Melis F. Rapid identification of high-risk transient ischemic attacks: prospective validation of the ABCD score. Stroke 2008;39(2):297-302.

  116. Rothwell PM, Buchan A, Johnston SC. Recent advances in management of transient ischaemic attacks and minor ischaemic strokes. Lancet Neurol 2006;5(4):323-31.

  117. Eliasziw M, Kennedy J, Hill MD, Buchan AM, Barnett HJ. Early risk of stroke after a transient ischemic attack in patients with internal carotid artery disease. CMAJ 2004;170(7):1105-9.

  118. Wardlaw JM, Chappell FM, Stevenson M, De Nigris E, Thomas S, Gillard J, et al. Accurate, practical and cost-effective assessment of carotid stenosis in the UK. Health Technol Assess 2006;10(30).

  119. Rothwell PM, Eliasziw M, Gutnikov SA, Warlow CP, Barnett HJ. Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. Lancet 2004;363(9413):915-24.

  120. Fairhead JF, Mehta Z, Rothwell PM. Population-based study of delays in carotid imaging and surgery and the risk of recurrent stroke. Neurology 2005;65(3):371-5.

  121. Fuster V, Ryden LE, Asinger RW, Cannom DS, Crijns HJ, Frye RL, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation): developed in Collaboration With the North American Society of Pacing and Electrophysiology. J Am Coll Cardiol 2001;38(4):1231-66.

  122. Paciaroni M, Hennerici M, Agnelli G, Bogousslavsky J. Statins and stroke prevention. Cerebrovasc Dis 2007;24(2-3):170-82.

  123. Barber M, Wright F, Stott DJ, Langhorne P. Predictors of early neurological deterioration after ischaemic stroke: a case-control study. Gerontology 2004;50(2):102-9.

  124. Jörgensen HS, Nakayama H, Raaschou HO, Olsen TS. Progredierende apopleksi. Incidens, risikofaktorer og prognose - the Copenhagen Stroke Study. Ugeskr Laeger 1995;157(25):3619-22.

  125. Steinke W, Ley SC. Lacunar stroke is the major cause of progressive motor deficits. Stroke 2002;33(6):1510-6.

  126. Britton M, Roden A. Progression of stroke after arrival at hospital. Stroke 1985;16(4):629-32.

  127. Garde E, Lassen NA. Apopleksi med hastigt progredierende symptomer - stroke in progression. Haemodynamiske og kliniske aspekter. Ugeskr Laeger 1995;157(30):4234-9.

  128. Roden-Jullig A, Britton M. Effectiveness of heparin treatment for progressing ischaemic stroke: before and after study. J Intern Med 2000;248(4):287-91.

  129. Diener HC, Bogousslavsky J, Brass LM, Cimminiello C, Csiba L, Kaste M, et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet 2004;364(9431):331-7.

  130. Mayer SA, Brun NC, Begtrup K, Broderick J, Davis S, Diringer MN, et al. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 2008;358(20):2127-37.

  131. Butler AC, Tait RC. Management of oral anticoagulant-induced intracranial haemorrhage. Blood Rev 1998;12(1):35-44.

  132. Christoforidis GA, Slivka A, Mohammad Y, Karakasis C, Avutu B, Yang M. Size matters: hemorrhage volume as an objective measure to define significant intracranial hemorrhage associated with thrombolysis. Stroke 2007;38(6):1799-804.

  133. Derex L, Hermier M, Adeleine P, Pialat JB, Wiart M, Berthezene Y, et al. Clinical and imaging predictors of intracerebral haemorrhage in stroke patients treated with intravenous tissue plasminogen activator. J Neurol Neurosurg Psychiatry 2005;76(1):70-5.

  134. Singer OC, Humpich MC, Fiehler J, Albers GW, Lansberg MG, Kastrup A, et al. Risk for symptomatic intracerebral hemorrhage after thrombolysis assessed by diffusion-weighted magnetic resonance imaging. Ann Neurol 2008;63(1):52-60.

  135. Broderick J, Connolly S, Feldmann E, Hanley D, Kase C, Krieger D, et al. Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Stroke 2007;38(6):2001-23.

  136. Mendelow AD, Gregson BA, Fernandes HM, Murray GD, Teasdale GM, Hope DT, et al. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial. Lancet 2005;365(9457):387-97.

  137. Teernstra OP, Evers SM, Kessels AH. Meta analyses in treatment of spontaneous supratentorial intracerebral haematoma. Acta Neurochir 2006;148(5):521-8.

  138. Salvesen R, Ingebrigtsen T. Spontan intracerebral blødning. Tidsskr Nor Lægeforen 2007;127(8):1064-8.

  139. Mitchell P, Gregson BA, Vindlacheruvu RR, Mendelow AD. Surgical options in ICH including decompressive craniectomy. J Neurol Sci 2007;261(1-2):89-98.

  140. Morgenstern LB, Demchuk AM, Kim DH, Frankowski RF, Grotta JC. Rebleeding leads to poor outcome in ultra-early craniotomy for intracerebral hemorrhage. Neurology 2001;56(10):1294-9.

  141. Mathew P, Teasdale G, Bannan A, Oluoch-Olunya D. Neurosurgical management of cerebellar haematoma and infarct. J Neurol Neurosurg Psychiatry 1995;59(3):287-92.

  142. Naff NJ, Hanley DF, Keyl PM, Tuhrim S, Kraut M, Bederson J, et al. Intraventricular thrombolysis speeds blood clot resolution: results of a pilot, prospective, randomized, double-blind, controlled trial. Neurosurgery 2004;54(3):577-83.

  143. Sulter G, Elting JW, Stewart R, den Arend A, De Keyser J. Continuous pulse oximetry in acute hemiparetic stroke. J Neurol Sci 2000;179(S 1-2):65-9.

  144. Bennett MH, Wasiak J, Schnabel A, Kranke P, French C. Hyperbaric oxygen therapy for acute ischaemic stroke. Cochrane Database Syst Rev 2005;(3):CD004954.

  145. Chiu EH, Liu CS, Tan TY, Chang KC. Venturi mask adjuvant oxygen therapy in severe acute ischemic stroke. Arch Neurol 2006;63(5):741-4.

  146. Ronning OM, Guldvog B. Should stroke victims routinely receive supplemental oxygen? A quasi-randomized controlled trial. Stroke 1999;30(10):2033-7.

  147. Bath P, Chalmers J, Powers W, Beilin L, Davis S, Lenfant C, et al. International Society of Hypertension (ISH): statement on the management of blood pressure in acute stroke. J Hypertens 2003;21(4):665-72.

  148. Blood pressure in Acute Stroke Collaboration (BASC). Interventions for deliberately altering blood pressure in acute stroke. Cochrane Database Syst Rev 2001;(3):CD000039.

  149. Mistri AK, Robinson TG, Potter JF. Pressor therapy in acute ischemic stroke: systematic review. Stroke 2006;37(6):1565-71.

  150. Keezer MR, Yu AY, Zhu B, Wolfson C, Cote R. Blood pressure and antihypertensive therapy as predictors of early outcome in acute ischemic stroke. Cerebrovasc Dis 2008;25(3):202-8.166

  151. Fuentes B, Diez-Tejedor E. General care in stroke: relevance of glycemia and blood pressure levels. Cerebrovasc Dis 2007;24(Suppl 1):134-42.

  152. Horn J, Limburg M. Calcium antagonists for acute ischemic stroke. Cochrane Database Syst Rev 2000;(2):CD001928.

  153. Bath PM, Willmot M, Leonardi-Bee J, Bath FJ. Nitric oxide donors (nitrates), L-arginine, or nitric oxide synthase inhibitors for acute stroke. Cochrane Database Syst Rev 2002;(4):CD000398.

  154. Barer DH, Cruickshank JM, Ebrahim SB, Mitchell JR. Low dose beta blockade in acute stroke (“BEST” trial): an evaluation. Br Med J 1988;296(6624):737-41.

  155. Schrader J, Luders S, Kulschewski A, Berger J, Zidek W, Treib J, et al. The ACCESS Study: evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors. Stroke 2003;34(7):1699-703.

  156. Qureshi AI, Mohammad YM, Yahia AM, Suarez JI, Siddiqui AM, Kirmani JF, et al. A prospective multicenter study to evaluate the feasibility and safety of aggressive antihypertensive treatment in patients with acute intracerebral hemorrhage. J Intensive Care Med 2005;20(1):34-42.

  157. Cheitlin MD, Armstrong WF, Aurigemma GP, Beller GA, Bierman FZ, Davis JL, et al. ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). Circulation 2003;108(9):1146-62.

  158. Bhalla A, Sankaralingam S, Dundas R, Swaminathan R, Wolfe CD, Rudd AG. Influence of raised plasma osmolality on clinical outcome after acute stroke. Stroke 2000;31(9):2043-8.

  159. Asplund K. Haemodilution for acute ischaemic stroke. Cochrane Database Syst Rev 2002;(4):CD000103.

  160. Hajat C, Hajat S, Sharma P. Effects of poststroke pyrexia on stroke outcome: a meta-analysis of studies in patients. Stroke 2000;31(2):410-4.

  161. Kammersgaard LP, Jorgensen HS, Rungby JA, Reith J, Nakayama H, Weber UJ, et al. Admission body temperature predicts long-term mortality after acute stroke: the Copenhagen Stroke Study. Stroke 2002;33(7):1759-62.

  162. Leira R, Rodriguez-Yanez M, Castellanos M, Blanco M, Nombela F, Sobrino T, et al. Hyperthermia is a surrogate marker of inflammation-mediated cause of brain damage in acute ischaemic stroke. J Intern Med 2006;260(4):343-9.

  163. Kasner SE, Wein T, Piriyawat P, Villar-Cordova CE, Chalela JA, Krieger DW, et al. Acetaminophen for altering body temperature in acute stroke: a randomized clinical trial. Stroke 2002;33(1):130-4.

  164. Dippel DW, van Breda EJ, van Gemert HM, van der Worp HB, Meijer RJ, Kappelle LJ, et al. Effect of paracetamol (acetaminophen) on body temperature in acute ischemic stroke: a double-blind, randomized phase II clinical trial. Stroke 2001;32(7):1607-12.

  165. Correia M, Silva M, Veloso M. Cooling therapy for acute stroke. Cochrane Database Syst Rev 2000;(2):CD001247.

  166. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003;26(Suppl 1):S5-20.

  167. Pulsinelli WA, Levy DE, Sigsbee B, Scherer P, Plum F. Increased damage after ischemic stroke in patients with hyperglycemia with or without established diabetes mellitus. Am J Med 1983;74(4):540-4.

  168. Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 2001;32(10):2426-32.

  169. Alvarez-Sabin J, Molina CA, Ribo M, Arenillas JF, Montaner J, Huertas R, et al. Impact of admission hyperglycemia on stroke outcome after thrombolysis: risk stratification in relation to time to reperfusion. Stroke 2004;35(11):2493-8.

  170. Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, et al. Intensive insulin therapy in the medical ICU. N Engl J Med 2006;354(5):449-61.

  171. Gray CS, Hildreth AJ, Sandercock PA, O’Connell JE, Johnston DE, Cartlidge NE, et al. Glucose-potassium-insulin infusions in the management of post-stroke hyperglycaemia: the UK Glucose Insulin in Stroke Trial (GIST-UK). Lancet Neurol 2007;6(5):397-406.

  172. Walters MR, Weir CJ, Lees KR. A randomised, controlled pilot study to investigate the potential benefit of intervention with insulin in hyperglycaemic acute ischaemic stroke patients. Cerebrovasc Dis 2006;22(2-3):116-22.

  173. Bruno A, Kent TA, Coull BM, Shankar RR, Saha C, Becker KJ, et al. Treatment of hyperglycemia in ischemic stroke (THIS): a randomized pilot trial. Stroke 2008;39(2):384-9.

  174. Langhorne P, Stott DJ, Robertson L, MacDonald J, Jones L, McAlpine C, et al. Medical complications after stroke: a multicenter study. Stroke 2000;31(6):1223-9.

  175. Indredavik B, Rohweder G, Naalsund E, Lydersen S. Medical complications in a comprehensive stroke unit and an early supported discharge service. Stroke 2008;39(2):414-20.

  176. Govan L, Langhorne P, Weir CJ. Does the prevention of complications explain the survival benefit of organized inpatient (stroke unit) care?: further analysis of a systematic review. Stroke 2007;38(9):2536-40.

  177. Camilo O, Goldstein LB. Seizures and epilepsy after ischemic stroke. Stroke 2004;35(7):1769-75.

  178. Burn J, Dennis M, Bamford J, Sandercock P, Wade D, Warlow C. Epileptic seizures after a first stroke: the Oxfordshire Community Stroke Project. BMJ 1997;315(7122):1582-7.

  179. Bardutzky J, Schwab S. Antiedema therapy in ischemic stroke. Stroke 2007;38(11):3084-94.

  180. Diringer MN, Edwards DF. Admission to a neurologic/neurosurgical intensive care unit is associated with reduced mortality rate after intracerebral hemorrhage. Crit Care Med 2001;29(3):635-40.

  181. Thomassen L, Brainin M, Demarin V, Grond M, Toni D, Venables GS. Acute stroke treatment in Europe: a questionnaire-based survey on behalf of the EFNS Task Force on acute neurological stroke care. Eur J Neurol 2003;10(3):199-204.

  182. Prass K, Meisel C, Hoflich C, Braun J, Halle E, Wolf T, et al. Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation. J Exp Med 2003;198(5):725-36.

  183. Katzan IL, Cebul RD, Husak SH, Dawson NV, Baker DW. The effect of pneumonia on mortality among patients hospitalized for acute stroke. Neurology 2003;60(4):620-5.

  184. Weimar C, Roth MP, Zillessen G, Glahn J, Wimmer ML, Busse O, et al. Complications following acute ischemic stroke. Eur Neurol 2002;48(3):133-40.

  185. Davenport RJ, Dennis MS, Wellwood I, Warlow CP. Complications after acute stroke. Stroke 1996;27(3):415-20.

  186. Sellars C, Bowie L, Bagg J, Sweeney MP, Miller H, Tilston J, et al. Risk factors for chest infection in acute stroke: a prospective cohort study. Stroke 2007;38(8):2284-91.

  187. Martino R, Foley N, Bhogal S, Diamant N, Speechley M, Teasell R. Dysphagia after stroke: incidence, diagnosis, and pulmonary complications. Stroke 2005;36(12):2756-63.

  188. Bravata DM, Ho SY, Meehan TP, Brass LM, Concato J. Readmission and death after hospitalization for acute ischemic stroke: 5-year follow-up in the medicare population. Stroke 2007;38(6):1899-904.168

  189. Hinchey JA, Shephard T, Furie K, Smith D, Wang D, Tonn S. Formal dysphagia screening protocols prevent pneumonia. Stroke 2005;36(9):1972-6.

  190. Wu J, Baguley IJ. Urinary retention in a general rehabilitation unit: prevalence, clinical outcome, and the role of screening. Arch Phys Med Rehabil 2005;86(9):1772-7.

  191. Ersoz M, Ulusoy H, Oktar MA, Akyuz M. Urinary tract infection and bacteriurua in stroke patients: frequencies, pathogen microorganisms, and risk factors. Am J Phys Med Rehabil 2007;86(9):734-41.

  192. Sherman DG. Prevention of venous thromboembolism, recurrent stroke, and other vascular events after acute ischemic stroke: the role of low-molecular-weight heparin and antiplatelet therapy. J Stroke Cerebrovasc Dis 2006;15(6):250-9.

  193. Kelly J, Rudd A, Lewis RR, Coshall C, Moody A, Hunt BJ. Venous thromboembolism after acute ischemic stroke: a prospective study using magnetic resonance direct thrombus imaging. Stroke 2004;35(10):2320-5.

  194. Dennis M, Sandercock PA, Reid J, Graham C, Murray G, Venables G, et al. Effectiveness of thigh-length graduated compression stockings to reduce the risk of deep vein thrombosis after stroke (CLOTS trial 1): a multicentre, randomised controlled trial. Lancet 2009;373(9679):1958-65.

  195. Teasell R, McRae M, Foley N, Bhardwaj A. The incidence and consequences of falls in stroke patients during inpatient rehabilitation: factors associated with high risk. Arch Phys Med Rehabil 2002;83(3):329-33.

  196. Ada L, Foongchomcheay A. Efficacy of electrical stimulation in preventing or reducing subluxation of the shoulder after stroke: a meta-analysis. Aust J Physiother 2002;48(4):257-67.

  197. Lindgren I, Jonsson AC, Norrving B, Lindgren A. Shoulder pain after stroke: prospective population-based study. Stroke 2007;38(2):343-8.

  198. Chae J, Mascarenhas D, Yu DT, Kirsteins A, Elovic EP, Flanagan SR, et al. Poststroke shoulder pain: its relationship to motor impairment, activity limitation, and quality of life. Arch Phys Med Rehabil 2007;88(3):298-301.

  199. Price CI, Pandyan AD. Electrical stimulation for preventing and treating post-stroke shoulder pain: a systematic Cochrane review. Clin Rehabil 2001;15(1):5-19.

  200. Ginn KA, Cohen ML. Conservative treatment for shoulder pain: prognostic indicators of outcome. Arch Phys Med Rehabil 2004;85(8):1231-5.

  201. Hanger HC, Whitewood P, Brown G, Ball MC, Harper J, Cox R, et al. A randomized controlled trial of strapping to prevent post-stroke shoulder pain. Clin Rehabil 2000;14(4):370-80.

  202. Griffin A, Bernhardt J. Strapping the hemiplegic shoulder prevents development of pain during rehabilitation: a randomized controlled trial. Clin Rehabil 2006;20(4):287-95.

  203. Ada L, Foongchomcheay A, Canning C. Supportive devices for preventing and treating subluxation of the shoulder after stroke. Cochrane Database Syst Rev 2005;(1):CD003863.

  204. Marco E, Duarte E, Vila J, Tejero M, Guillen A, Boza R, et al. Is botulinum toxin type A effective in the treatment of spastic shoulder pain in patients after stroke? A double-blind randomized clinical trial. J Rehabil Med 2007;39(6):440-7.

  205. Yelnik AP, Colle FM, Bonan IV, Vicaut E. Treatment of shoulder pain in spastic hemiplegia by reducing spasticity of the subscapular muscle: a randomised, double blind, placebo controlled study of botulinum toxin A. J Neurol Neurosurg Psychiatry 2007;78(8):845-8.

  206. Kong KH, Neo JJ, Chua KS. A randomized controlled study of botulinum toxin A in the treatment of hemiplegic shoulder pain associated with spasticity. Clin Rehabil 2007;21(1):28-35.

  207. Lim JY, Koh JH, Paik NJ. Intramuscular botulinum toxin-A reduces hemiplegic shoulder pain: a randomized, double-blind, comparative study versus intraarticular triamcinolone acetonide. Stroke 2008;39(1):126-31.

  208. McManus J, Pathansali R, Stewart R, Macdonald A, Jackson S. Delirium post-stroke. Age Ageing 2007;36(6):613-8.

  209. Sheng AZ, Shen Q, Cordato D, Zhang YY, Yin Chan DK. Delirium within three days of stroke in a cohort of elderly patients. J Am Geriatr Soc 2006;54(8):1192-8.

  210. Ranhoff AH. Medikamentell behandling av delirium hos eldre. Tidsskr Nor Lægeforen 2004;124(23):3072-4.

  211. Ferro JM, Caeiro L, Verdelho A. Delirium in acute stroke. Curr Opin Neurol 2002;15(1):51-5.

  212. Gustafson Y, Lundström M, Bucht G, Edlund A. Delirium hos gamla människor kan förebyggas och behandlas. Tidsskr Nor Lægeforen 2002;122(8):810-4.

  213. Davenport RJ, Dennis MS, Warlow CP. Gastrointestinal hemorrhage after acute stroke. Stroke 1996;27(3):421-4.

  214. Misra UK, Kalita J, Pandey S, Mandal SK. Predictors of gastrointestinal bleeding in acute intracerebral haemorrhage. J Neurol Sci 2003;208(1-2):25-9.

  215. Tønseth KA, Villanger O. Stressulcus. Tidsskr Nor Lægeforen 2003;123(9):1195-7.

  216. Bath PM, Bath FJ, Smithard DG. Interventions for dysphagia in acute stroke. Cochrane Database Syst Rev 2000;(2):CD000323.

  217. Perry L. Screening swallowing function of patients with acute stroke. Part one: Identification, implementation and initial evaluation of a screening tool for use by nurses. J Clin Nurs 2001;10(4):463-73.

  218. Engedal K, Wyller TB. Aldring og hjernesykdommer. Oslo: Akribe; 2003.

  219. Trapl M, Enderle P, Nowotny M, Teuschl Y, Matz K, Dachenhausen A, et al. Dysphagia bedside screening for acute-stroke patients: the Gugging Swallowing Screen. Stroke 2007;38(11):2948-52.

  220. Wekre LL, Vardeberg K, Skogan AH. Lærebok i rehabilitering: når livet blir annerledes. Bergen: Fagbokforlaget; 2004.

  221. Rugås L, Rasmussen AF, Presberg LB, Opsahl G. Svelgetesting hindrer dødsfall. Sykepleien 2005;93(9):66-7.

  222. Dennis MS, Lewis SC, Warlow C. Effect of timing and method of enteral tube feeding for dysphagic stroke patients (FOOD): a multicentre randomised controlled trial. Lancet 2005;365(9461):764-72.

  223. Legg L, Drummond A, Leonardi-Bee J, Gladman JR, Corr S, Donkervoort M, et al. Occupational therapy for patients with problems in personal activities of daily living after stroke: systematic review of randomised trials. BMJ 2007;335(7626):922.

  224. Kalra L, Langhorne P. Facilitating recovery: evidence for organized stroke care. J Rehabil Med 2007;39(2):97-102.

  225. Touze E, Gauvrit JY, Moulin T, Meder JF, Bracard S, Mas JL. Risk of stroke and recurrent dissection after a cervical artery dissection: a multicenter study. Neurology 2003;61(10):1347-51.

  226. Engelter ST, Lyrer PA, Kirsch EC, Steck AJ. Long-term follow-up after extracranial internal carotid artery dissection. Eur Neurol 2000;44(4):199-204.

  227. Jacobs A, Lanfermann H, Neveling M, Szelies B, Schroder R, Heiss WD. MRI- and MRA-guided therapy of carotid and vertebral artery dissections. J Neurol Sci 1997;147(1):27-34.

  228. Schievink WI. The treatment of spontaneous carotid and vertebral artery dissections. Curr Opin Cardiol 2000;15(5):316-21.

  229. Lyrer P, Engelter S. Antithrombotic drugs for carotid artery dissection. Cochrane Database Syst Rev 2003;(3):CD000255.170

  230. Muller BT, Luther B, Hort W, Neumann-Haefelin T, Aulich A, Sandmann W. Surgical treatment of 50 carotid dissections: indications and results. J Vasc Surg 2000;31(5):980-8.

  231. Malek AM, Higashida RT, Phatouros CC, Lempert TE, Meyers PM, Smith WS, et al. Endovascular management of extracranial carotid artery dissection achieved using stent angioplasty. AJNR Am J Neuroradiol 2000;21(7):1280-92.

  232. Bousser M, Barnett HJ. Cerebral venous thrombosis. I: Mohr JP, Choi DW, Grotta JC, Weir B, Wolf PA, red. Stroke. Patophysiology, diagnosis, and management. Philadelphia: Churchill Livingstone; 2004. s. 301-25.

  233. Georgiadis D, Scwab S, Hacke W. Critical care of the patient with acute stroke. I: Mohr JP, Choi DW, Grotta JC, Weir B, Wolf PA, red. Stroke. Patophysiology, diagnosis, and management. Philadelphia: Churchill Livingstone; 2004. s. 987-1024.

  234. de Bruijn SF, Stam J. Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis. Stroke 1999;30(3):484-8.

  235. Stam J, de Bruijn SF, DeVeber G. Anticoagulation for cerebral sinus thrombosis. Cochrane Database Syst Rev 2002;(4):CD002005.

  236. Einhaupl KM, Villringer A, Meister W, Mehraein S, Garner C, Pellkofer M, et al. Heparin treatment in sinus venous thrombosis. Lancet 1991;338(8767):597-600.

  237. Ciccone A, Canhao P, Falcao F, Ferro JM, Sterzi R. Thrombolysis for cerebral vein and dural sinus thrombosis. Cochrane Database Syst Rev 2004;(1):CD003693.

  238. Kurth T, Slomke MA, Kase CS, Cook NR, Lee IM, Gaziano JM, et al. Migraine, headache, and the risk of stroke in women: a prospective study. Neurology 2005;64(6):1020-6.

  239. Stang PE, Carson AP, Rose KM, Mo J, Ephross SA, Shahar E, et al. Headache, cerebrovascular symptoms, and stroke: the Atherosclerosis Risk in Communities Study. Neurology 2005;64(9):1573-7.

  240. Buring JE, Hebert P, Romero J, Kittross A, Cook N, Manson J, et al. Migraine and subsequent risk of stroke in the Physicians’ Health Study. Arch Neurol 1995;52(2):129-34.

  241. MacClellan LR, Giles W, Cole J, Wozniak M, Stern B, Mitchell BD, et al. Probable migraine with visual aura and risk of ischemic stroke: the stroke prevention in young women study. Stroke 2007;38(9):2438-45.

  242. Etminan M, Takkouche B, Isorna FC, Samii A. Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observational studies. BMJ 2005;330(7482):63.

  243. Tzourio C, Tehindrazanarivelo A, Iglesias S, Alperovitch A, Chedru F, d’Anglejan-Chatillon J, et al. Case-control study of migraine and risk of ischaemic stroke in young women. BMJ 1995;310(6983):830-3.

  244. Chang CL, Donaghy M, Poulter N. Migraine and stroke in young women: case-control study. The World Health Organisation Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. BMJ 1999;318(7175):13-8.

  245. Hall GC, Brown MM, Mo J, MacRae KD. Triptans in migraine: the risks of stroke, cardiovascular disease, and death in practice. Neurology 2004;62(4):563-8.

  246. Velentgas P, Cole JA, Mo J, Sikes CR, Walker AM. Severe vascular events in migraine patients. Headache 2004;44(7):642-51.

  247. Wammes-van der Heijden EA, Rahimtoola H, Leufkens HG, Tijssen CC, Egberts AC. Risk of ischemic complications related to the intensity of triptan and ergotamine use. Neurology 2006;67(7):1128-34.

  248. Schwerzmann M, Wiher S, Nedeltchev K, Mattle HP, Wahl A, Seiler C, et al. Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacks. Neurology 2004;62(8):1399-401.

  249. Diener HC, Kurth T, Dodick D. Patent foramen ovale, stroke, and cardiovascular disease in migraine. Curr Opin Neurol 2007;20(3):310-9.

  250. Langhorne P, Dey P, Woodman M, Kalra L, Wood-Dauphinee S, Patel N, et al. Is stroke unit care portable? A systematic review of the clinical trials. Age Ageing 2005;34(4):324-30.

  251. Langhorne P, Cadilhac D, Feigin V, Grieve R, Liu M. How should stroke services be organised? Lancet Neurol 2002;1(1):62-8.

  252. Indredavik B, Bakke F, Slordahl SA, Rokseth R, Haheim LL. Treatment in a combined acute and rehabilitation stroke unit: which aspects are most important? Stroke 1999;30(5):917-23.

  253. Fjærtoft H, Indredavik B. Rehabilitering av pasienter med hjerneslag. Tidsskr Nor Lægeforen 2007;127(4):442-5.

  254. Organised inpatient (stroke unit) care for stroke. Cochrane Database Syst Rev 2002;(1):CD000197.

  255. How do stroke units improve patient outcomes? A collaborative systematic review of the randomized trials. Stroke Unit Trialists Collaboration. Stroke 1997;28(11):2139-44.

  256. Thommessen B, Wyller TB. Sykehusbasert rehabilitering etter hjerneslag. Tidsskr Nor Lægeforen 2007;127(9):1224-7.

  257. Diez-Tejedor E, Fuentes B. Homeostasis as basis of acute stroke treatment: stroke units are the key. Cerebrovasc Dis 2005;20(Suppl 2):129-34.

  258. Sprigg N, Gray LJ, Bath PM, Boysen G, De Deyn PP, Friis P, et al. Relationship between outcome and baseline blood pressure and other haemodynamic measures in acute ischaemic stroke: data from the TAIST trial. J Hypertens 2006;24(7):1413-7.

  259. Sulter G, Elting JW, Langedijk M, Maurits NM, De Keyser J. Admitting acute ischemic stroke patients to a stroke care monitoring unit versus a conventional stroke unit: a randomized pilot study. Stroke 2003;34(1):101-4.

  260. Silva Y, Puigdemont M, Castellanos M, Serena J, Suner RM, Garcia MM, et al. Semi-intensive monitoring in acute stroke and long-term outcome. Cerebrovasc Dis 2005;19(1):23-30.

  261. Cavallini A, Micieli G, Marcheselli S, Quaglini S. Role of monitoring in management of acute ischemic stroke patients. Stroke 2003;34(11):2599-603.

  262. Jones SP, Leathley MJ, McAdam JJ, Watkins CL. Physiological monitoring in acute stroke: a literature review. J Adv Nurs 2007;60(6):577-94.

  263. Ilmavarta M, Frey H, Erila T, Fogelholm R. Stroke outcome and outcome of brain infarction: a prospective randomised controlled study comparing the outcome for patients with acute brain infarction treated in a stroke unit and in an ordinary neurological ward [dissertation]. Tampere, Finland: University of Tampere, Faculty of Medicine; 1994.

  264. Nasjonal veileder for beslutningsprosesser for begrensning av livsforlengende behandling hos alvorlig syke og døende. Oslo: Helsedirektoratet; 2009. Tilgjengelig fra: www.helsedirektoratet.no/vp/multimedia/archive/00117/Nasjonal_veileder_f_117069a.pdf

  265. Alberts MJ, Latchaw RE, Selman WR, Shephard T, Hadley MN, Brass LM, et al. Recommendations for comprehensive stroke centers: a consensus statement from the Brain Attack Coalition. Stroke 2005;36(7):1597-616.

  266. Goldstein LB, Matchar DB, Hoff-Lindquist J, Samsa GP, Horner RD. VA Stroke Study: neurologist care is associated with increased testing but improved outcomes. Neurology 2003;61(6):792-6.

  267. Mitchell JB, Ballard DJ, Whisnant JP, Ammering CJ, Samsa GP, Matchar DB. What role do neurologists play in determining the costs and outcomes of stroke patients? Stroke 1996;27(11):1937-43.

  268. Audebert H. Telestroke: effective networking. Lancet Neurol 2006;5(3):279-82. 172

  269. Audebert HJ, Schenkel J, Heuschmann PU, Bogdahn U, Haberl RL. Effects of the implementation of a telemedical stroke network: the Telemedic Pilot Project for Integrative Stroke Care (TEMPiS) in Bavaria, Germany. Lancet Neurol 2006;5(9):742-8.

  270. Hess DC, Wang S, Gross H, Nichols FT, Hall CE, Adams RJ. Telestroke: extending stroke expertise into underserved areas. Lancet Neurol 2006;5(3):275-8.

  271. Audebert HJ, Wimmer ML, Hahn R, Schenkel J, Bogdahn U, Horn M, et al. Can telemedicine contribute to fulfill WHO Helsingborg Declaration of specialized stroke care? Cerebrovasc Dis 2005;20(5):362-9.

  272. Levine SR, McConnochie KM. Telemedicine for acute stroke: when virtual is as good as reality. Neurology 2007;69(9):819-20.

  273. Schwab M, Fitzek C, Witte OW, Isenmann S. Extending the potential of perfusion imaging with MRI to prevent major stroke. Lancet Neurol 2007;6(2):102-4.

  274. Ickenstein GW, Horn M, Schenkel J, Vatankhah B, Bogdahn U, Haberl R, et al. The use of telemedicine in combination with a new stroke-code-box significantly increases t-PA use in rural communities. Neurocrit Care 2005;3(1):27-32.

  275. Ehlers L, Muskens WM, Jensen LG, Kjolby M, Andersen G. National use of thrombolysis with alteplase for acute ischaemic stroke via telemedicine in Denmark: a model of budgetary impact and cost effectiveness. CNS Drugs 2008;22(1):73-81.

  276. LaMonte MP, Bahouth MN, Xiao Y, Hu P, Baquet CR, Mackenzie CF. Outcomes from a comprehensive stroke telemedicine program. Telemed J E Health 2008;14(4):339-44.

  277. Frey JL, Jahnke HK, Goslar PW, Partovi S, Flaster MS. tPA by telephone: extending the benefits of a comprehensive stroke center. Neurology 2005;64(1):154-6.

  278. Handscu R, Scibor M, Willaczek B, Nuckel M, Heckmann JG, Asshoff D, et al. Telemedicine in acute stroke. Remote video-examination compared to simple telephone consultation. J Neurol 2010;255(11):1792-7.

  279. Meyer BC, Raman R, Hemmen T, Obler R, Zivin JA, Rao R, et al. Efficacy of site-independent telemedicine in the Stroke DOC trial: a randomised, blinded, prospective study. Lancet Neurol 2008;7(9):787-95.

  280. Burn J, Dennis M, Bamford J, Sandercock P, Wade D, Warlow C. Long-term risk of recurrent stroke after a first-ever stroke. The Oxfordshire Community Stroke Project. Stroke 1994;25(2):333-7.

  281. Eriksson SE, Olsson JE. Survival and recurrent strokes in patients with different subtypes of stroke: a fourteen-year follow-up study. Cerebrovasc Dis 2001;12(3):171-80.

  282. Waje-Andreassen U, Naess H, Thomassen L, Eide GE, Vedeler CA. Arterial events after ischemic stroke at a young age: a cross-sectional long-term follow-up of patients and controls in western Norway. Cerebrovasc Dis 2007;24(2-3):277-82.

  283. Landi G, Cella E, Boccardi E, Musicco M. Lacunar versus non-lacunar infarcts: pathogenetic and prognostic differences. J Neurol Neurosurg Psychiatry 1992;55(6):441-5.

  284. Naess H, Waje-Andreassen U, Thomassen L, Nyland H, Myhr KM. Do all young ischemic stroke patients need long-term secondary preventive medication? Neurology 2005;65(4):609-11.

  285. Saxena R, Koudstaal PJ. Anticoagulants for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischaemic attack. Cochrane Database Syst Rev 2004;(2):CD000185.

  286. Lo EH, Dalkara T, Moskowitz MA. Mechanisms, challenges and opportunities in stroke. Nat Rev Neurosci 2003;4(5):399-415.

  287. Touze E, Varenne O, Chatellier G, Peyrard S, Rothwell PM, Mas JL. Risk of myocardial infarction and vascular death after transient ischemic attack and ischemic stroke: a systematic review and meta-analysis. Stroke 2005;36(12):2747-55.

  288. Dhamoon MS, Sciacca RR, Rundek T, Sacco RL, Elkind MS. Recurrent stroke and cardiac risks after first ischemic stroke: the Northern Manhattan Study. Neurology 2006;66(5):641-6.

  289. Hankey GJ. Long term outcome after ischemic stroke/transient ischemic attach. Cerebrovasc Dis 2003;16(suppl 1):14-9.

  290. Amarenco P, Bogousslavsky J, Callahan A, III, Goldstein LB, Hennerici M, Rudolph AE, et al. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006;355(6):549-59.

  291. Counsell C, Boonyakarnkul S, Dennis M, Sandercock P, Bamford J, Burn J, et al. Primary Intracerebral Haemorrhage in the Oxfordshire Community Stroke Project. Cerebrovasc Dis 1995;5(1):26-34.

  292. Bailey RD, Hart RG, Benavente O, Pearce LA. Recurrent brain hemorrhage is more frequent than ischemic stroke after intracranial hemorrhage. Neurology 2001;56(6):773-7.

  293. Asplund K. Stroke: riskfaktorer och primärprevention. Läkartidningen 2009;100(44):3500-5.

  294. Wardlaw JM, Seymour J, Cairns J, Keir S, Lewis S, Sandercock P. Immediate computed tomography scanning of acute stroke is cost-effective and improves quality of life. Stroke 2004;35(11):2477-83.

  295. Levy S, Breithardt G, Campbell RW, Camm AJ, Daubert JC, Allessie M, et al. Atrial fibrillation: current knowledge and recommendations for management. Working Group on Arrhythmias of the European Society of Cardiology. Eur Heart J 1998;19(9):1294-320.

  296. Hankey GJ, Eikelboom JW, van Bockxmeer FM, Lofthouse E, Staples N, Baker RI. Inherited thrombophilia in ischemic stroke and its patogenic subtype. Stroke 2001;32(8):1793-9.

  297. Levine SR, Brey RL, Tilley BC, Thompson JL, Sacco RL, Sciacca RR, et al. Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke. JAMA 2004;291(5):576-84.

  298. Algra A, van Gijn J. Cumulative meta-analysis of aspirin efficacy after cerebral ischaemia of arterial origin. J Neurol Neurosurg Psychiatry 1999;66(2):255.

  299. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002;324(7329):71-86.

  300. De Schryver EL, Algra A, van Gijn J. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease. Cochrane Database Syst Rev 2007;(3):CD001820.

  301. Diener H-C, Davidai G. Dipyridamole and headache. Future Neurology 2007;2(3):279-83.

  302. Sacco RL, Diener HC, Yusuf S, Cotton D, Ounpuu S, Lawton WA, et al. Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. N Engl J Med 2008;359(12):1238-51.

  303. Bhatt DL, Fox KA, Hacke W, Berger PB, Black HR, Boden WE, et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med 2006;354(16):1706-17.

  304. Hankey GJ, Sudlow CL, Dunbabin DW. Thienopyridine derivatives (ticlopidine, clopidogrel) versus aspirin for preventing stroke and other serious vascular events in high vascular risk patients. Cochrane Database Syst Rev 2000;(2):CD001246.

  305. Saxena R, Lewis S, Berge E, Sandercock PA, Koudstaal PJ. Risk of early death and recurrent stroke and effect of heparin in 3169 patients with acute ischemic stroke and atrial fibrillation in the International Stroke Trial. Stroke 2001;32(10):2333-7.

  306. Saxena R, Koudstaal P. Anticoagulants versus antiplatelet therapy for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischemic attack. Cochrane Database Syst Rev 2004;(4):CD000187.

  307. Hylek EM, Singer DE. Risk factors for intracranial hemorrhage in outpatients taking warfarin. Ann Intern Med 1994;120(11):897-902.174

  308. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 2001;285(22):2864-70.

  309. Wang TJ, Massaro JM, Levy D, Vasan RS, Wolf PA, D’Agostino RB, et al. A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study. JAMA 2003;290(8):1049-56.

  310. Johannessen KA, Nordrehaug JE, von der LG. Left ventricular thrombosis and cerebrovascular accident in acute myocardial infarction. Br Heart J 1984;51(5):553-6.

  311. Loh E, Sutton MS, Wun CC, Rouleau JL, Flaker GC, Gottlieb SS, et al. Ventricular dysfunction and the risk of stroke after myocardial infarction. N Engl J Med 1997;336(4):251-7.

  312. van Es RF, Jonker JJ, Verheugt FW, Deckers JW, Grobbee DE. Aspirin and coumadin after acute coronary syndromes (the ASPECT-2 study): a randomised controlled trial. Lancet 2002;360(9327):109-13.

  313. McDonagh TA, Morrison CE, Lawrence A, Ford I, Tunstall-Pedoe H, McMurray JJ, et al. Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population. Lancet 1997;350(9081):829-33.

  314. Hays AG, Sacco RL, Rundek T, Sciacca RR, Jin Z, Liu R, et al. Left ventricular systolic dysfunction and the risk of ischemic stroke in a multiethnic population. Stroke 2006;37(7):1715-9.

  315. Massie BM, Collins JF, Ammon SE, Armstrong PW, Cleland JG, Ezekowitz M, et al. Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) trial. Circulation 2009;119(12):1616-24.

  316. Szekely P. Systemic embolism and anticoagulant prophylaxis in rheumatic heart disease. Br Med J 1964;1(5392):1209-12.

  317. Adams GF, Merrett JD, Hutchinson WM, Pollock AM. Cerebral embolism and mitral stenosis: survival with and without anticoagulants. J Neurol Neurosurg Psychiatry 1974;37(4):378-83.

  318. van Walraven C, Hart RG, Singer DE, Laupacis A, Connolly S, Petersen P, et al. Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis. JAMA 2002;288(19):2441-8.

  319. Silaruks S, Thinkhamrop B, Tantikosum W, Wongvipaporn C, Tatsanavivat P, Klungboonkrong V. A prognostic model for predicting the disappearance of left atrial thrombi among candidates for percutaneous transvenous mitral commissurotomy. J Am Coll Cardiol 2002;39(5):886-91.

  320. Boon A, Lodder J, Cheriex E, Kessels F. Risk of stroke in a cohort of 815 patients with calcification of the aortic valve with or without stenosis. Stroke 1996;27(5):847-51.

  321. Otto CM, Lind BK, Kitzman DW, Gersh BJ, Siscovick DS. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med 1999;341(3):142-7.

  322. Meschengieser SS, Fondevila CG, Frontroth J, Santarelli MT, Lazzari MA. Low-intensity oral anticoagulation plus low-dose aspirin versus high-intensity oral anticoagulation alone: a randomized trial in patients with mechanical prosthetic heart valves. J Thorac Cardiovasc Surg 1997;113(5):910-6.

  323. Homma S, Sacco RL, Di Tullio MR, Sciacca RR, Mohr JP. Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study. Circulation 2002;105(22):2625-31.

  324. Khairy P, O’Donnell CP, Landzberg MJ. Transcatheter closure versus medical therapy of patent foramen ovale and presumed paradoxical thromboemboli: a systematic review. Ann Intern Med 2003;139(9):753-60.

  325. Rashid P, Leonardi-Bee J, Bath P. Blood pressure reduction and secondary prevention of stroke and other vascular events: a systematic review. Stroke 2003;34(11):2741-8.

  326. Kjellström T, Norrving B, Shatchkute A, red. Helsingborg declaration 2006 on European Stroke Strategies. Copenhagen: WHO Regional Office for Europe; 2006. Tilgjengelig fra: www.euro.who.int/document/e89242.pdf

  327. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jr., et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003;289(19):2560-72.

  328. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 2001;358(9287):1033-41.

  329. Strippoli GF, Craig M, Craig JC. Antihypertensive agents for preventing diabetic kidney disease. Cochrane Database Syst Rev 2005;(4):CD004136.

  330. Yusuf S, Diener HC, Sacco RL, Cotton D, Ounpuu S, Lawton WA, et al. Telmisartan to prevent recurrent stroke and cardiovascular events. N Engl J Med 2008;359(12):1225-37.

  331. Sclater A, Alagiakrishnan K. Orthostatic hypotension. A primary care primer for assessment and treatment. Geriatrics 2004;59(8):22-7.

  332. Elliott WJ. Circadian variation in blood pressure: implications for the elderly patient. Am J Hypertens 1999;12(2 Pt 2):43S-9S.

  333. Beckett NS, Peters R, Fletcher AE, Staessen JA, Liu L, Dumitrascu D, et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med 2008;358(18):1887-98.

  334. Steinberg D, Glass CK, Witztum JL. Evidence mandating earlier and more aggressive treatment of hypercholesterolemia. Circulation 2008;118(6):672-7.

  335. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004;364(9438):937-52.

  336. Walldius G, Aastveit AH, Jungner I. Stroke mortality and the apoB/apoA-I ratio: results of the AMORIS prospective study. J Intern Med 2006;259(3):259-66.

  337. Navi BB, Segal AZ. The role of cholesterol and statins in stroke. Curr Cardiol Rep 2009;11(1):4-11.

  338. Holme I, Aastveit AH, Hammar N, Jungner I, Walldius G. Relationships between lipoprotein components and risk of ischaemic and haemorrhagic stroke in the Apolipoprotein MOrtality RISk study (AMORIS). J Intern Med 2009;265(2):275-87.

  339. Amarenco P, Labreuche J. Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention. Lancet Neurol 2009;8(5):453-63.

  340. Sofi F, Cesari F, Abbate R, Gensini GF, Casini A. Adherence to Mediterranean diet and health status: meta-analysis. BMJ 2008;337:a1344.

  341. Gaspardone A, Arca M. Atorvastatin: its clinical role in cerebrovascular prevention. Drugs 2007;67 (Suppl 1):55-62.

  342. Aronow WS, Ahn C, Gutstein H. Reduction of new coronary events and new atherothrombotic brain infarction in older persons with diabetes mellitus, prior myocardial infarction, and serum low-density lipoprotein cholesterol >/=125 mg/dl treated with statins. J Gerontol A Biol Sci Med Sci 2002;57(11):M747-M750.

  343. Aronow WS, Ahn C. Incidence of new coronary events in older persons with prior myocardial infarction and serum low-density lipoprotein cholesterol >or = 125 mg/dl treated with statins versus no lipid-lowering drug. Am J Cardiol 2002;89(1):67-9.

  344. Chaturvedi S, Zivin J, Breazna A, Amarenco P, Callahan A, Goldstein LB, et al. Effect of atorvastatin in elderly patients with a recent stroke or transient ischemic attack. Neurology 2009;72(8):688-94.

  345. Goldstein LB, Amarenco P, Szarek M, Callahan A, III, Hennerici M, Sillesen H, et al. Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study. Neurology 2008;70(24 Pt 2):2364-70.176

  346. Amarenco P, Goldstein LB, Szarek M, Sillesen H, Rudolph AE, Callahan A, III, et al. Effects of intense low-density lipoprotein cholesterol reduction in patients with stroke or transient ischemic attack: the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke 2007;38(12):3198-204.

  347. Grundy SM, Cleeman JI, Merz CN, Brewer HB, Jr., Clark LT, Hunninghake DB, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004;110(2):227-39.

  348. Colivicchi F, Bassi A, Santini M, Caltagirone C. Discontinuation of statin therapy and clinical outcome after ischemic stroke. Stroke 2007;38(10):2652-7.

  349. Blanco M, Nombela F, Castellanos M, Rodriguez-Yanez M, Garcia-Gil M, Leira R, et al. Statin treatment withdrawal in ischemic stroke: a controlled randomized study. Neurology 2007;69(9):904-10.

  350. Naess H, Nyland HI, Thomassen L, Aarseth J, Myhr KM. Long-term outcome of cerebral infarction in young adults. Acta Neurol Scand 2004;110(2):107-12.

  351. Petty GW, Brown RD, Jr., Whisnant JP, Sicks JD, O’Fallon WM, Wiebers DO. Survival and recurrence after first cerebral infarction: a population-based study in Rochester, Minnesota, 1975 through 1989. Neurology 1998;50(1):208-16.

  352. Hillen T, Coshall C, Tilling K, Rudd AG, McGovern R, Wolfe CD. Cause of stroke recurrence is multifactorial: patterns, risk factors, and outcomes of stroke recurrence in the South London Stroke Register. Stroke 2003;34(6):1457-63.

  353. Adler AI, Stratton IM, Neil HA, Yudkin JS, Matthews DR, Cull CA, et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ 2000;321(7258):412-9.

  354. American Diabetes Association. ADA Clinical practice recommendations. Diabetes Care 2004;27(Suppl 1).

  355. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352(9131):837-53.

  356. Chambers BR, Donnan GA. Carotid endarterectomy for asymptomatic carotid stenosis. Cochrane Database Syst Rev 2005;(4):CD001923.

  357. Goldstein LB, Adams R, Alberts MJ, Appel LJ, Brass LM, Bushnell CD, et al. Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: the American Academy of Neurology affirms the value of this guideline. Stroke 2006;37(6):1583-633.

  358. Kang S, Wu Y, Li X. Effects of statin therapy on the progression of carotid atherosclerosis: a systematic review and meta-analysis. Atherosclerosis 2004;177(2):433-42.

  359. Collins R, Armitage J, Parish S, Sleight P, Peto R, Hart Protection Study Collaborative Group. Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions. Lancet 2004;363(9411):757-67.

  360. Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet 1998;351(9113):1379-87.

  361. Barnett HJ, Taylor DW, Eliasziw M, Fox AJ, Ferguson GG, Haynes RB, et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 1998;339(20):1415-25.

  362. Cina CS, Clase CM, Haynes RB. Carotid endarterectomy for symptomatic carotid stenosis. Cochrane Database Syst Rev 2000;(2):CD001081.

  363. Rothwell PM, Eliasziw M, Gutnikov SA, Fox AJ, Taylor DW, Mayberg MR, et al. Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis. Lancet 2003;361(9352):107-16.

  364. Coward LJ, Featherstone RL, Brown MM. Safety and efficacy of endovascular treatment of carotid artery stenosis compared with carotid endarterectomy: a Cochrane systematic review of the randomized evidence. Stroke 2005;36(4):905-11.

  365. Mas JL, Chatellier G, Beyssen B, Branchereau A, Moulin T, Becquemin JP, et al. Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. N Engl J Med 2006;355(16):1660-71.

  366. Wiesmann M, Schopf V, Jansen O, Bruckmann H. Stent-protected angioplasty versus carotid endarterectomy in patients with carotid artery stenosis: meta-analysis of randomized trial data. Eur Radiol 2008;18(12):2956-66.

  367. Kern R, Ringleb PA, Hacke W, Mas JL, Hennerici MG. Stenting for carotid artery stenosis. Nat Clin Pract Neurol 2007;3(4):212-20.

  368. Potempa K, Lopez M, Braun LT, Szidon JP, Fogg L, Tincknell T. Physiological outcomes of aerobic exercise training in hemiparetic stroke patients. Stroke 1995;26(1):101-5.

  369. Chu KS, Eng JJ, Dawson AS, Harris JE, Ozkaplan A, Gylfadottir S. Water-based exercise for cardiovascular fitness in people with chronic stroke: a randomized controlled trial. Arch Phys Med Rehabil 2004;85(6):870-4.

  370. Macko RF, Smith GV, Dobrovolny CL, Sorkin JD, Goldberg AP, Silver KH. Treadmill training improves fitness reserve in chronic stroke patients. Arch Phys Med Rehabil 2001;82(7):879-84.

  371. Saunders DH, Greig CA, Young A, Mead GE. Physical fitness training for stroke patients. Cochrane Database Syst Rev 2004;(1):CD003316.

  372. Amundsen BH, Wisloff U, Slørdahl SA. Fysisk trening ved hjerte- og karsykdommer. Tidsskr Nor Lægeforen 2007;127(4):446-8.

  373. Wendel-Vos GC, Schuit AJ, Feskens EJ, Boshuizen HC, Verschuren WM, Saris WH, et al. Physical activity and stroke. A meta-analysis of observational data. Int J Epidemiol 2004;33(4):787-98.

  374. Lee CD, Folsom AR, Blair SN. Physical activity and stroke risk: a meta-analysis. Stroke 2003;34(10):2475-81.

  375. Hu FB, Stampfer MJ, Colditz GA, Ascherio A, Rexrode KM, Willett WC, et al. Physical activity and risk of stroke in women. JAMA 2000;283(22):2961-7.

  376. Lee IM, Paffenbarger RS, Jr. Physical activity and stroke incidence: the Harvard Alumni Health Study. Stroke 1998;29(10):2049-54.

  377. Wisloff U, Nilsen TI, Droyvold WB, Morkved S, Slordahl SA, Vatten LJ. A single weekly bout of exercise may reduce cardiovascular mortality: how little pain for cardiac gain? ‘The HUNT study, Norway’. Eur J Cardiovasc Prev Rehabil 2006;13(5):798-804.

  378. Ellekjaer H, Holmen J, Ellekjaer E, Vatten L. Physical activity and stroke mortality in women. Ten-year follow-up of the Nord-Trondelag health survey, 1984-1986. Stroke 2000;31(1):14-8.

  379. Whelton SP, Chin A, Xin X, He J. Effect of aerobic exercise on blood pressure: a meta-analysis of randomized, controlled trials. Ann Intern Med 2002;136(7):493-503.

  380. Thomas DE, Elliott EJ, Naughton GA. Exercise for type 2 diabetes mellitus. Cochrane Database Syst Rev 2006;3:CD002968.

  381. Borg G. Borg’s perceived exertion and pain scales. Champaign, Ill: Human Kinetics; 1998.178

  382. Gordon NF, Gulanick M, Costa F, Fletcher G, Franklin BA, Roth EJ, et al. Physical activity and exercise recommendations for stroke survivors: an American Heart Association scientific statement from the Council on Clinical Cardiology, Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention; the Council on Cardiovascular Nursing; the Council on Nutrition, Physical Activity, and Metabolism; and the Stroke Council. Circulation 2004;109(16):2031-41.

  383. Bahr R, red. Aktivitetshåndboken: fysisk aktivitet i forebygging og behandling. Oslo: Helsedirektoratet; 2009. Tilgjengelig fra: www.helsedirektoratet.no/vp/multimedia/archive/00105/Aktivitetsh_ndboken_105169a.pdf

  384. Galimanis A, Mono ML, Arnold M, Nedeltchev K, Mattle HP. Lifestyle and stroke risk: a review. Curr Opin Neurol 2009;22(1):60-8.

  385. He K, Merchant A, Rimm EB, Rosner BA, Stampfer MJ, Willett WC, et al. Dietary fat intake and risk of stroke in male US healthcare professionals: 14 year prospective cohort study. BMJ 2003;327(7418):777-82.

  386. Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med 2001;344(1):3-10.

  387. He FJ, MacGregor GA. Effect of longer-term modest salt reduction on blood pressure. Cochrane Database Syst Rev 2004;(3):CD004937.

  388. Reynolds K, Lewis B, Nolen JD, Kinney GL, Sathya B, He J. Alcohol consumption and risk of stroke: a meta-analysis. JAMA 2003;289(5):579-88.

  389. Shinton R, Beevers G. Meta-analysis of relation between cigarette smoking and stroke. BMJ 1989;298(6676):789-94.

  390. Wannamethee SG, Shaper AG, Whincup PH, Walker M. Smoking cessation and the risk of stroke in middle-aged men. JAMA 1995;274(2):155-60.

  391. Kawachi I, Colditz GA, Stampfer MJ, Willett WC, Manson JE, Rosner B, et al. Smoking cessation and decreased risk of stroke in women. JAMA 1993;269(2):232-6.

  392. Stead LF, Perera R, Bullen C, Mant D, Lancaster T. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2008;(1):CD000146.

  393. Røykeavvenning i primærhelsetjenesten. Retningslinjer for primærhelsetjenestens arbeid med røykeavvenning. Oslo: Sosial- og helsedirektoratet; 2004. Tilgjengelig fra: www.helsedirektoratet.no/vp/multimedia/archive/00001/R_ykeavvenning_i_prim_1860a.pdf

  394. Stead LF, Perera R, Lancaster T. Telephone counselling for smoking cessation. Cochrane Database Syst Rev 2006;3:CD002850.

  395. Kurth T, Gaziano JM, Berger K, Kase CS, Rexrode KM, Cook NR, et al. Body mass index and the risk of stroke in men. Arch Intern Med 2002;162(22):2557-62.

  396. Selmer R, Tverdal A. Body mass index and cardiovascular mortality at different levels of blood pressure: a prospective study of Norwegian men and women. J Epidemiol Community Health 1995;49(3):265-70.

  397. Anderson JW, Konz EC. Obesity and disease management: effects of weight loss on comorbid conditions. Obes Res 2001;9(Suppl 4):326S-34S.

  398. Sacco RL, Adams R, Albers G, Alberts MJ, Benavente O, Furie K, et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke 2006;37(2):577-617.

  399. Mas JL, Lamy C. Stroke in pregnancy and the puerperium. J Neurol 1998;245(6-7):305-13.

  400. Kittner SJ, Stern BJ, Feeser BR, Hebel R, Nagey DA, Buchholz DW, et al. Pregnancy and the risk of stroke. N Engl J Med 1996;335(11):768-74.

  401. Kozer E, Nikfar S, Costei A, Boskovic R, Nulman I, Koren G. Aspirin consumption during the first trimester of pregnancy and congenital anomalies: a meta-analysis. Am J Obstet Gynecol 2002;187(6):1623-30.

  402. Imperiale TF, Petrulis AS. A meta-analysis of low-dose aspirin for the prevention of pregnancy-induced hypertensive disease. JAMA 1991;266(2):260-4.

  403. CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group. Lancet 1994;343(8898):619-29.

  404. Duley L, Henderson-Smart DJ, Knight M, King JF. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev 2004;(1):CD004659.

  405. Bates SM, Greer IA, Hirsh J, Ginsberg JS. Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126(3 Suppl):627S-44S.

  406. Kazmin A, Garcia-Bournissen F, Koren G. Risks of statin use during pregnancy: a systematic review. J Obstet Gynaecol Can 2007;29(11):906-8.

  407. Broderick JP, Adams HP, Jr., Barsan W, Feinberg W, Feldmann E, Grotta J, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 1999;30(4):905-15.

  408. Gillman MW, Cupples LA, Gagnon D, Posner BM, Ellison RC, Castelli WP, et al. Protective effect of fruits and vegetables on development of stroke in men. JAMA 1995;273(14):1113-7.

  409. Donahue RP, Abbott RD, Reed DM, Yano K. Alcohol and hemorrhagic stroke. The Honolulu Heart Program. JAMA 1986;255(17):2311-4.

  410. Dietrichs E. Hjernens plastisitet - perspektiver for rehabilitering etter hjerneslag. Tidsskr Nor Lægeforen 2007;127(9):1228-31.

  411. Sosial- og helsedepartementet. Ansvar og meistring. Mot ein heilskapeleg rehabiliteringspolitikk. St.meld. nr. 21 (1998-1999). Tilgjengelig fra: www.regjeringen.no

  412. Veileder i rehabilitering av slagrammede. Oslo: Statens helsetilsyn; 1996. Veiledningsserie 4-96.

  413. Forskrift om habilitering og rehabilitering. FOR-2001-06-28-765.

  414. Forskrift om individuell plan etter helselovgivningen og sosialtjenesteloven. FOR-2004-12-23-1837.

  415. Helse- og omsorgsdepartementet. Nasjonal strategi for habilitering og rehabilitering 2008-2011. Særtrykk av St.prp. nr.1 (2007-2008) kapittel 9. Tilgjengelig fra: www.regjeringen.no

  416. Langhorne P, Dennis M. Stroke units: an evidence based approach. London: BMJ Books; 1998.

  417. Langhorne P, Duncan P. Does the organization of postacute stroke care really matter? Stroke 2001;32(1):268-74.

  418. Garfelt B. Rehabilitering etter hjerneslag: en studie av rehabiliteringstilbudet ved alders- og sykehjem i Hedmark fylke [masteroppgave]. Oslo: Universitetet i Oslo; 2007. Tilgjengelig fra: www.duo.uio.no/sok/work.html?WORKID=59128

  419. Fjaertoft H, Indredavik B, Johnsen R, Lydersen S. Acute stroke unit care combined with early supported discharge. Long-term effects on quality of life. A randomized controlled trial. Clin Rehabil 2004;18(5):580-6.

  420. Thorsen AM, Holmqvist LW, Pedro-Cuesta J, von Koch L. A randomized controlled trial of early supported discharge and continued rehabilitation at home after stroke: five-year follow-up of patient outcome. Stroke 2005;36(2):297-303.180

  421. Ronning OM, Guldvog B. Outcome of subacute stroke rehabilitation: a randomized controlled trial. Stroke 1998;29(4):779-84.

  422. Askim T, Rohweder G, Lydersen S, Indredavik B. Evaluation of an extended stroke unit service with early supported discharge for patients living in a rural community. A randomized controlled trial. Clin Rehabil 2004;18(3):238-48.

  423. Johansson BB. Functional outcome in rats transferred to an enriched environment 15 days after focal brain ischemia. Stroke 1996;27(2):324-6.

  424. Britton M, Andersson A. Home rehabilitation after stroke. Reviewing the scientific evidence on effects and costs. Int J Technol Assess Health Care 2000;16(3):842-8.

  425. Baskett JJ, Broad JB, Reekie G, Hocking C, Green G. Shared responsibility for ongoing rehabilitation: a new approach to home-based therapy after stroke. Clin Rehabil 1999;13(1):23-33.

  426. Roderick P, Low J, Day R, Peasgood T, Mullee MA, Turnbull JC, et al. Stroke rehabilitation after hospital discharge: a randomized trial comparing domiciliary and day-hospital care. Age Ageing 2001;30(4):303-10.

  427. Forster A, Young J, Lambley R, Langhorne P. Medical day hospital care for the elderly versus alternative forms of care. Cochrane Database Syst Rev 2008;(4):CD001730.

  428. Lincoln NB, Walker MF, Dixon A, Knights P. Evaluation of a multiprofessional community stroke team: a randomized controlled trial. Clin Rehabil 2004;18(1):40-7.

  429. Walker MF, Leonardi-Bee J, Bath P, Langhorne P, Dewey M, Corr S, et al. Individual patient data meta-analysis of randomized controlled trials of community occupational therapy for stroke patients. Stroke 2004;35(9):2226-32.

  430. Dekker R, Drost EA, Groothoff JW, Arendzen JH, van Gijn JC, Eisma WH. Effects of day-hospital rehabilitation in stroke patients: a review of randomized clinical trials. Scand J Rehabil Med 1998;30(2):87-94.

  431. Stette Ø, red. Opplæringslova med forskrifter: forarbeid og kommentarer 2005; lov om grunnskolen og den vidaregåande opplæringa (opplæringslova); forskrifter til opplæringslova. Oslo: PEDLEX norsk skoleinformasjon; 2005.

  432. Robey RR. A meta-analysis of clinical outcomes in the treatment of aphasia. J Speech Lang Hear Res 1998;41(1):172-87.

  433. Språk- og talevansker hos voksne: veileder til kommunene. Oslo: VOX; 2004.

  434. Indredavik B. Slagmanual - En veiledning i diagnostikk, observasjon, akutt behandling og akutt rehabilitering i Slagenheten. Trondheim: St. Olavs hospital, avdeling for hjerneslag; 2007.

  435. Foley N, Salter K, Teasell R. Specialized stroke services: a meta-analysis comparing three models of care. Cerebrovasc Dis 2007;23(2-3):194-202.

  436. Kasner SE. Clinical interpretation and use of stroke scales. Lancet Neurol 2006;5(7):603-12.

  437. van Peppen RP, Hendriks HJ, van Meeteren NL, Helders PJ, Kwakkel G. The development of a clinical practice stroke guideline for physiotherapists in The Netherlands: a systematic review of available evidence. Disabil Rehabil 2007;29(10):767-83.

  438. Salter KL, Teasell RW, Foley NC, Jutai JW. Outcome assessment in randomized controlled trials of stroke rehabilitation. Am J Phys Med Rehabil 2007;86(12):1007-12.

  439. Meyer BC, Hemmen TM, Jackson CM, Lyden PD. Modified National Institutes of Health Stroke Scale for use in stroke clinical trials: prospective reliability and validity. Stroke 2002;33(5):1261-6.

  440. Christensen H, Boysen G, Truelsen T. The Scandinavian Stroke Scale Predicts Outcome in Patients with Mild Ischemic Stroke. Cerebrovasc Dis 2005;20:46-8.181

  441. Mahoney FI, Barthel DW. Functional evaluation: the Barthel index. Md State Med J 1965;14:61-5.

  442. Rankin J. Cerebral vascular accidents in patients over the age of 60. II. Prognosis. Scott Med J 1957;2(5):200-15.

  443. Fugl-Meyer AR, Jaasko L, Leyman I, Olsson S, Steglind S. The post-stroke hemiplegic patient. 1:a method for evaluation of physical performance. Scand J Rehabil Med 1975;7(1):13-31.

  444. Carr JH, Shepherd RB, Nordholm L, Lynne D. Investigation of a new motor assessment scale for stroke patients. Phys Ther 1985;65(2):175-80.

  445. Demeurisse G, Demol O, Robaye E. Motor evaluation in vascular hemiplegia. Eur Neurol 1980;19(6):382-9.

  446. Lincoln N, Leadbitter D. Assessment of motor function in stroke patients. Physiotherapy 1979;65(2):48-51.

  447. Lyle RC. A performance test for assessment of upper limb function in physical rehabilitation treatment and research. Int J Rehabil Res 1981;4(4):483-92.

  448. Mathiowetz V, Weber K, Kashman N, Volland G. Adult Norms for the Nine Hole Peg Test Of Finger Dexterity. The Occupational Therapy Journal of Research 1985;5(1):24-37.

  449. Heller A, Wade DT, Wood VA, Sunderland A, Hewer RL, Ward E. Arm function after stroke: measurement and recovery over the first three months. J Neurol Neurosurg Psychiatry 1987;50(6):714-9.

  450. Wolf SL, Catlin PA, Ellis M, Archer AL, Morgan B, Piacentino A. Assessing Wolf motor function test as outcome measure for research in patients after stroke. Stroke 2001;32(7):1635-9.

  451. Berg K, Wood-Dauphinee S, Williams JI. The Balance Scale: reliability assessment with elderly residents and patients with an acute stroke. Scand J Rehabil Med 1995;27(1):27-36.

  452. Podsiadlo D, Richardson S. The timed “Up & Go”: a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc 1991;39(2):142-8.

  453. Salbach NM, Mayo NE, Higgins J, Ahmed S, Finch LE, Richards CL. Responsiveness and predictability of gait speed and other disability measures in acute stroke. Arch Phys Med Rehabil 2001;82(9):1204-12.

  454. Holden MK, Gill KM, Magliozzi MR, Nathan J, Piehl-Baker L. Clinical gait assessment in the neurologically impaired. Reliability and meaningfulness. Phys Ther 1984;64(1):35-40.

  455. Verheyden G, Nieuwboer A, Van de WA, De Weerdt W. Clinical tools to measure trunk performance after stroke: a systematic review of the literature. Clin Rehabil 2007;21(5):387-94.

  456. Franchignoni FP, Tesio L, Ricupero C, Martino MT. Trunk control test as an early predictor of stroke rehabilitation outcome. Stroke 1997;28(7):1382-5.

  457. Reinvang I, Engvik H. Norsk grunntest for afasi: handbok. Oslo: Pensumtjeneste; 1995.

  458. Howard D, Patterson K, oversatt til norsk av Corneliussen M. Pyramide- og palmetesten: undersøker tilgang til semantisk kunnskap via ord og bilder. Oslo: Novus; 2005.

  459. Thoresen GE, Thommesen B. Ullevål afasiscreening test (UAS). Oslo: Ullevål sykehus; 1999.

  460. Kay J, Lesser R, Coltheart M. PALPA: psykolingvistisk kartlegging av språkprosessering hos afasirammede (Psycholinguistic assessment of language processing in aphasia). Oslo: Novus; 2009.

  461. Enderby PM. Frenchay dysartritest. Oslo: Novus; 1998.

  462. Tester og registreringsskjemaer [nettside]. Oslo: Norsk geriatrisk forening; Den norske legeforening [oppdatert 2009; lest 10 mar 2009]. Tilgjengelig fra: www.legeforeningen.no/id/18662.0

  463. Wilson B, Cockburn J, Baddeley A, Hiorns R. The development and validation of a test battery for detecting and monitoring everyday memory problems. J Clin Exp Neuropsychol 1989;11(6):855-70.182

  464. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Pyschiatry 1979;134:382-9.

  465. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67(6): 361-70.

  466. Granger CV, Hamilton BB, Keith RA, Zielesny M, Sherwin FS. Advances in functional assessment for medical rehabilitation. Top Geriatr Rehabil 1986;(1):59-74.

  467. Wade DT, Legh-Smith J, Langton Hewer R. Social activities after stroke: measurement and natural history using the Frenchay Activities Index. Int Rehabil Med 1985;7(4):176-81.

  468. Fisher AG. Assessment of motor and process skills. Vol. 1: Development, standardization, and administration manual. Forth Collins, CO: Three star press; 2006.

  469. Duncan PW, Wallace D, Lai SM, Johnson D, Embretson S, Laster LJ. The stroke impact scale version 2.0. Evaluation of reliability, validity, and sensitivity to change. Stroke 1999;30(10):2131-40.

  470. Lundberg C, Caneman G, Samuelsson SM, Hakamies-Blomqvist L, Almkvist O. The assessment of fitness to drive after a stroke: the Nordic Stroke Driver Screening Assessment. Scand J Psychol 2003;44(1):23-30.

  471. van de Port IG, Kwakkel G, van W, I, Lindeman E. Susceptibility to deterioration of mobility long-term after stroke: a prospective cohort study. Stroke 2006;37(1):167-71.

  472. Hendricks HT, van Limbeek J, Geurts AC, Zwarts MJ. Motor recovery after stroke: a systematic review of the literature. Arch Phys Med Rehabil 2002;83(11):1629-37.

  473. Kwakkel G, Kollen BJ, van der GJ, Prevo AJ. Probability of regaining dexterity in the flaccid upper limb: impact of severity of paresis and time since onset in acute stroke. Stroke 2003;34(9):2181-6.

  474. Holliday RC, Cano S, Freeman JA, Playford ED. Should patients participate in clinical decision making? An optimised balance block design controlled study of goal setting in a rehabilitation unit. J Neurol Neurosurg Psychiatry 2007;78(6):576-80.

  475. Holliday RC, Ballinger C, Playford ED. Goal setting in neurological rehabilitation: patients’ perspectives. Disabil Rehabil 2007;29(5):389-94.

  476. Collaborative systematic review of the randomised trials of organised inpatient (stroke unit) care after stroke. Stroke Unit Trialists’ Collaboration. BMJ 1997;314(7088):1151-9.

  477. Bakas T, Austin JK, Jessup SL, Williams LS, Oberst MT. Time and difficulty of tasks provided by family caregivers of stroke survivors. J Neurosci Nurs 2004;36(2):95-106.

  478. Grant JS, Glandon GL, Elliott TR, Giger JN, Weaver M. Caregiving problems and feelings experienced by family caregivers of stroke survivors the first month after discharge. Int J Rehabil Res 2004;27(2):105-11.

  479. Bhogal SK, Teasell RW, Foley NC, Speechley MR. Community reintegration after stroke. Top Stroke Rehabil 2003;10(2):107-29.

  480. Ski C, O’Connell B. Stroke: the increasing complexity of carer needs. J Neurosci Nurs 2007;39(3):172-9.

  481. Lee J, Soeken K, Picot SJ. A meta-analysis of interventions for informal stroke caregivers. West J Nurs Res 2007;29(3):344-56.

  482. Individuell plan 2007. Veileder til forskrift om individuell plan. Oslo: Sosial- og helsedirektoratet; 2007. Tilgjengelig fra: http://www.helsedirektoratet.no/habilitering_rehabilitering/individuell_plan/

  483. Jorgensen HS, Reith J, Nakayama H, Kammersgaard LP, Raaschou HO, Olsen TS. What determines good recovery in patients with the most severe strokes? The Copenhagen Stroke Study. Stroke 1999;30(10):2008-12.

  484. Ouellette MM, LeBrasseur NK, Bean JF, Phillips E, Stein J, Frontera WR, et al. High-intensity resistance training improves muscle strength, self-reported function, and disability in long-term stroke survivors. Stroke 2004;35(6):1404-9.

  485. Ada L, Dean CM, Hall JM, Bampton J, Crompton S. A treadmill and overground walking program improves walking in persons residing in the community after stroke: a placebo-controlled, randomized trial. Arch Phys Med Rehabil 2003;84(10):1486-91.

  486. Werner RA, Kessler S. Effectiveness of an intensive outpatient rehabilitation program for postacute stroke patients. Am J Phys Med Rehabil 1996;75(2):114-20.

  487. Slot KB, Berge E, Dorman P, Lewis S, Dennis M, Sandercock P. Impact of functional status at six months on long term survival in patients with ischaemic stroke: prospective cohort studies. BMJ 2008;336(7640):376-9.

  488. Eriksson M, Norrving B, Terent A, Stegmayr B. Functional outcome 3 months after stroke predicts long-term survival. Cerebrovasc Dis 2008;25(5):423-9.

  489. Aziz NA, Leonardi-Bee J, Phillips M, Gladman JR, Legg L, Walker MF. Therapy-based rehabilitation services for patients living at home more than one year after stroke. Cochrane Database Syst Rev 2008;(2):CD005952.

  490. Demain S, Wiles R, Roberts L, McPherson K. Recovery plateau following stroke: fact or fiction? Disabil Rehabil 2006;28(13-14):815-21.

  491. Jones F. Strategies to enhance chronic disease self-management: how can we apply this to stroke? Disabil Rehabil 2006;28(13-14):841-7.

  492. Edelman GM. Neural darwinism: the theory of neuronal group selection. New York: Basic Books; 1987.

  493. Edelman GM. Bright air, brilliant fire: on the matter of the mind. New York: Basic Books; 1992.

  494. Sigmundsson H, Haga M, red. Motorikk og samfunn: en samfunnsvitenskapelig tilnærming til motorisk atferd. Oslo: Sebu forlag; 2004.

  495. French B, Thomas LH, Leathley MJ, Sutton CJ, McAdam J, Forster A, et al. Repetitive task training for improving functional ability after stroke. Cochrane Database Syst Rev 2007;(4):CD006073.

  496. van Peppen RP, Kwakkel G, Wood-Dauphinee S, Hendriks HJ, Van der Wees PJ, Dekker J. The impact of physical therapy on functional outcomes after stroke: what’s the evidence? Clin Rehabil 2004;18(8):833-62.

  497. Kollen BJ, Lennon S, Lyons B, Wheatley-Smith L, Scheper M, Buurke JH, et al. The effectiveness of the Bobath concept in stroke rehabilitation: what is the evidence? Stroke 2009;40(4):e89-e97.

  498. Langhorne P, Coupar F, Pollock A. Motor recovery after stroke: a systematic review. Lancet Neurol 2009;8(8):741-54.

  499. Pollock A, Baer G, Pomeroy V, Langhorne P. Physiotherapy treatment approaches for the recovery of postural control and lower limb function following stroke. Cochrane Database Syst Rev 2007;(1):CD001920.

  500. Braun SM, Beurskens AJ, Borm PJ, Schack T, Wade DT. The effects of mental practice in stroke rehabilitation: a systematic review. Arch Phys Med Rehabil 2006;87(6):842-52.

  501. Sharma N, Pomeroy VM, Baron JC. Motor imagery: a backdoor to the motor system after stroke? Stroke 2006;37(7):1941-52.

  502. Zimmermann-Schlatter A, Schuster C, Puhan MA, Siekierka E, Steurer J. Efficacy of motor imagery in post-stroke rehabilitation: a systematic review. J Neuroeng Rehabil 2008;5:8.

  503. Ramachandran VS, Altschuler EL. The use of visual feedback, in particular mirror visual feedback, in restoring brain function. Brain 2009;132(Pt 7):1693-710.184

  504. Ezendam D, Bongers RM, Jannink MJ. Systematic review of the effectiveness of mirror therapy in upper extremity function. Disabil Rehabil 2009;31(26):2135-49.

  505. Celnik P, Webster B, Glasser DM, Cohen LG. Effects of action observation on physical training after stroke. Stroke 2008;39(6):1814-20.

  506. Canning CG, Ada L, Adams R, O’Dwyer NJ. Loss of strength contributes more to physical disability after stroke than loss of dexterity. Clin Rehabil 2004;18(3):300-8.

  507. Ada L, Dorsch S, Canning CG. Strengthening interventions increase strength and improve activity after stroke: a systematic review. Aust J Physiother 2006;52(4):241-8.

  508. Yang YR, Wang RY, Lin KH, Chu MY, Chan RC. Task-oriented progressive resistance strength training improves muscle strength and functional performance in individuals with stroke. Clin Rehabil 2006;20(10):860-70.

  509. Morris SL, Dodd KJ, Morris ME. Outcomes of progressive resistance strength training following stroke: a systematic review. Clin Rehabil 2004;18(1):27-39.

  510. Pomeroy VM, King L, Pollock A, Baily-Hallam A, Langhorne P. Electrostimulation for promoting recovery of movement or functional ability after stroke. Cochrane Database Syst Rev 2006;(2):CD003241.

  511. Hama S, Yamashita H, Shigenobu M, Watanabe A, Hiramoto K, Takimoto Y, et al. Sitting balance as an early predictor of functional improvement in association with depressive symptoms in stroke patients. Psychiatry Clin Neurosci 2007;61(5):543-51.

  512. Harley C, Boyd JE, Cockburn J, Collin C, Haggard P, Wann JP, et al. Disruption of sitting balance after stroke: influence of spoken output. J Neurol Neurosurg Psychiatry 2006;77(5):674-6.

  513. Langhammer B, Lindmark B, Stanghelle JK. Stroke patients and long-term training: is it worthwhile? A randomized comparison of two different training strategies after rehabilitation. Clin Rehabil 2007;21(6):495-510.

  514. Dean CM, Shepherd RB. Task-related training improves performance of seated reaching tasks after stroke. A randomized controlled trial. Stroke 1997;28(4):722-8.

  515. Dean CM, Channon EF, Hall JM. Sitting training early after stroke improves sitting ability and quality and carries over to standing up but not to walking: a randomised trial. Aust J Physiother 2007;53(2):97-102.

  516. Pollock AS, Durward BR, Rowe PJ, Paul JP. The effect of independent practice of motor tasks by stroke patients: a pilot randomized controlled trial. Clin Rehabil 2002;16(5):473-80.

  517. Mudie MH, Winzeler-Mercay U, Radwan S, Lee L. Training symmetry of weight distribution after stroke: a randomized controlled pilot study comparing task-related reach, Bobath and feedback training approaches. Clin Rehabil 2002;16(6):582-92.

  518. Lin JH, Hsieh CL, Hsiao SF, Huang MH. Predicting long-term care institution utilization among postrehabilitation stroke patients in Taiwan: a medical centre-based study. Disabil Rehabil 2001;23(16):722-30.

  519. Meijer R, van Limbeek J, Peusens G, Rulkens M, Dankoor K, Vermeulen M, et al. The Stroke Unit Discharge Guideline, a prognostic framework for the discharge outcome from the hospital stroke unit. A prospective cohort study. Clin Rehabil 2005;19(7):770-8.

  520. Barclay-Goddard R, Stevenson T, Poluha W, Moffatt ME, Taback SP. Force platform feedback for standing balance training after stroke. Cochrane Database Syst Rev 2004;(4):CD004129.

  521. van Peppen RP, Kortsmit M, Lindeman E, Kwakkel G. Effects of visual feedback therapy on postural control in bilateral standing after stroke: a systematic review. J Rehabil Med 2006;38(1):3-9.

  522. Pohl M, Mehrholz J. Immediate effects of an individually designed functional ankle-foot orthosis on stance and gait in hemiparetic patients. Clin Rehabil 2006;20(4):324-30.185

  523. Jorgensen HS, Nakayama H, Raaschou HO, Olsen TS. Recovery of walking function in stroke patients: the Copenhagen Stroke Study. Arch Phys Med Rehabil 1995;76(1):27-32.

  524. Pang MY, Eng JJ, Dawson AS, Gylfadottir S. The use of aerobic exercise training in improving aerobic capacity in individuals with stroke: a meta-analysis. Clin Rehabil 2006;20(2):97-111.

  525. van de Port IG, Wood-Dauphinee S, Lindeman E, Kwakkel G. Effects of exercise training programs on walking competency after stroke: a systematic review. Am J Phys Med Rehabil 2007;86(11):935-51.

  526. Moseley AM, Stark A, Cameron ID, Pollock A. Treadmill training and body weight support for walking after stroke. Cochrane Database Syst Rev 2005;(4):CD002840.

  527. Sullivan KJ, Brown DA, Klassen T, Mulroy S, Ge T, Azen SP, et al. Effects of task-specific locomotor and strength training in adults who were ambulatory after stroke: results of the STEPS randomized clinical trial. Phys Ther 2007;87(12):1580-602.

  528. Mehrholz J, Werner C, Kugler J, Pohl M. Electromechanical-assisted training for walking after stroke. Cochrane Database Syst Rev 2007;(4):CD006185.

  529. Wolf SL, Winstein CJ, Miller JP, Taub E, Uswatte G, Morris D, et al. Effect of constraint-induced movement therapy on upper extremity function 3 to 9 months after stroke: the EXCITE randomized clinical trial. JAMA 2006;296(17):2095-104.

  530. Wolf SL, Winstein CJ, Miller JP, Thompson PA, Taub E, Uswatte G, et al. Retention of upper limb function in stroke survivors who have received constraint-induced movement therapy: the EXCITE randomised trial. Lancet Neurol 2008;7(1):33-40.

  531. Bjørklund A, Fecht A. The effectiveness of constraint-induced therapy as a stroke intervention: a meta-analysis. Occupational Therapy in Health Care 2006;20(2):31-49.

  532. Platz T, Winter T, Muller N, Pinkowski C, Eickhof C, Mauritz KH. Arm ability training for stroke and traumatic brain injury patients with mild arm paresis: a single-blind, randomized, controlled trial. Arch Phys Med Rehabil 2001;82(7):961-8.

  533. Stewart KC, Cauraugh JH, Summers JJ. Bilateral movement training and stroke rehabilitation: a systematic review and meta-analysis. J Neurol Sci 2006;244(1-2):89-95.

  534. Hesse S, Werner C, Pohl M, Rueckriem S, Mehrholz J, Lingnau ML. Computerized arm training improves the motor control of the severely affected arm after stroke: a single-blinded randomized trial in two centers. Stroke 2005;36(9):1960-6.

  535. Masiero S, Celia A, Rosati G, Armani M. Robotic-assisted rehabilitation of the upper limb after acute stroke. Arch Phys Med Rehabil 2007;88(2):142-9.

  536. Kwakkel G, Kollen BJ, Krebs HI. Effects of robot-assisted therapy on upper limb recovery after stroke: a systematic review. Neurorehabil Neural Repair 2008;22(2):111-21.

  537. Meilink A, Hemmen B, Seelen HA, Kwakkel G. Impact of EMG-triggered neuromuscular stimulation of the wrist and finger extensors of the paretic hand after stroke: a systematic review of the literature. Clin Rehabil 2008;22(4):291-305.

  538. van Kuijk AA, Geurts AC, Bevaart BJ, van Limbeek J. Treatment of upper extremity spasticity in stroke patients by focal neuronal or neuromuscular blockade: a systematic review of the literature. J Rehabil Med 2002;34(2):51-61.

  539. Kerse N, Parag V, Feigin VL, McNaughton H, Hackett ML, Bennett DA, et al. Falls after stroke: results from the Auckland Regional Community Stroke (ARCOS) Study, 2002 to 2003. Stroke 2008;39(6):1890-3.

  540. Ashburn A, Hyndman D, Pickering R, Yardley L, Harris S. Predicting people with stroke at risk of falls. Age Ageing 2008;37(3):270-6.

  541. Cheng PT, Wu SH, Liaw MY, Wong AM, Tang FT. Symmetrical body-weight distribution training in stroke patients and its effect on fall prevention. Arch Phys Med Rehabil 2001;82(12):1650-4.186

  542. Cheng PT, Wang CM, Chung CY, Chen CL. Effects of visual feedback rhythmic weight-shift training on hemiplegic stroke patients. Clin Rehabil 2004;18(7):747-53.

  543. Barreca S, Sigouin CS, Lambert C, Ansley B. Effects of Extra Training on the Ability of Stroke Survivors to Perform an Independent Sit-to-Stand: A Randomized Controlled Trial. J Geriatr Phys Ther 2004;27(2):59-64.

  544. Parker MJ, Gillespie WJ, Gillespie LD. Hip protectors for preventing hip fractures in older people. Cochrane Database Syst Rev 2005;(3):CD001255.

  545. Lyons RA, John A, Brophy S, Jones SJ, Johansen A, Kemp A, et al. Modification of the home environment for the reduction of injuries. Cochrane Database Syst Rev 2006;(4):CD003600.

  546. Gillespie LD, Gillespie WJ, Robertson MC, Lamb SE, Cumming RG, Rowe BH. Interventions for preventing falls in elderly people. Cochrane Database Syst Rev 2001;(3):CD000340.

  547. Connell LA, Lincoln NB, Radford KA. Somatosensory impairment after stroke: frequency of different deficits and their recovery. Clin Rehabil 2008;22(8):758-67.

  548. Tyson SF, Hanley M, Chillala J, Selley AB, Tallis RC. Sensory loss in hospital-admitted people with stroke: characteristics, associated factors, and relationship with function. Neurorehabil Neural Repair 2008;22(2):166-72.

  549. Byl N, Roderick J, Mohamed O, Hanny M, Kotler J, Smith A, et al. Effectiveness of sensory and motor rehabilitation of the upper limb following the principles of neuroplasticity: patients stable poststroke. Neurorehabil Neural Repair 2003;17(3):176-91.

  550. Sommerfeld DK, Eek EU, Svensson AK, Holmqvist LW, von Arbin MH. Spasticity after stroke: its occurrence and association with motor impairments and activity limitations. Stroke 2004;35(1):134-9.

  551. Cardoso E, Pedreira G, Prazeres A, Ribeiro N, Melo A. Does botulinum toxin improve the function of the patient with spasticity after stroke? Arq Neuropsiquiatr 2007;65(3A):592-5.

  552. Rousseaux M, Kozlowski O, Froger J. Efficacy of botulinum toxin A in upper limb function of hemiplegic patients. J Neurol 2002;249(1):76-84.

  553. Rousseaux M, Launay MJ, Kozlowski O. Post stroke hemiplegia: interest of botulinum toxin injection at the upper limb. Ann Readapt Med Phys 2003;46(6):286-95.

  554. Cardoso E, Rodrigues B, Lucena R, Oliveira IR, Pedreira G, Melo A. Botulinum toxin type A for the treatment of the upper limb spasticity after stroke: a meta-analysis. Arq Neuropsiquiatr 2005;63(1):30-3.

  555. Brashear A, McAfee AL, Kuhn ER, Fyffe J. Botulinum toxin type B in upper-limb poststroke spasticity: a double-blind, placebo-controlled trial. Arch Phys Med Rehabil 2004;85(5):705-9.

  556. Meythaler JM, Guin-Renfroe S, Brunner RC, Hadley MN. Intrathecal baclofen for spastic hypertonia from stroke. Stroke 2001;32(9):2099-109.

  557. Montane E, Vallano A, Laporte JR. Oral antispastic drugs in nonprogressive neurologic diseases: a systematic review. Neurology 2004;63(8):1357-63.

  558. Lannin NA, Herbert RD. Is hand splinting effective for adults following stroke? A systematic review and methodologic critique of published research. Clin Rehabil 2003;17(8):807-16.

  559. Bovend’Eerdt TJ, Newman M, Barker K, Dawes H, Minelli C, Wade DT. The effects of stretching in spasticity: a systematic review. Arch Phys Med Rehabil 2008;89(7):1395-406.

  560. Ward AB, Aguilar M, De Beyl Z, Gedin S, Kanovsky P, Molteni F, et al. Use of botulinum toxin type A in management of adult spasticity. A European consensus statement. Eura Medicophys 2004;40(2):83-4.

  561. Ada L, Goddard E, McCully J, Stavrinos T, Bampton J. Thirty minutes of positioning reduces the development of shoulder external rotation contracture after stroke: a randomized controlled trial. Arch Phys Med Rehabil 2005;86(2):230-4.

  562. Gustafsson L, McKenna K. A programme of static positional stretches does not reduce hemiplegic shoulder pain or maintain shoulder range of motion--a randomized controlled trial. Clin Rehabil 2006;20(4):277-86.

  563. de Jong LD, Nieuwboer A, Aufdemkampe G. Contracture preventive positioning of the hemiplegic arm in subacute stroke patients: a pilot randomized controlled trial. Clin Rehabil 2006;20(8):656-67.

  564. Horsley SA, Herbert RD, Ada L. Four weeks of daily stretch has little or no effect on wrist contracture after stroke: a randomised controlled trial. Aust J Physiother 2007;53(4):239-45.

  565. Turton AJ, Britton E. A pilot randomized controlled trial of a daily muscle stretch regime to prevent contractures in the arm after stroke. Clin Rehabil 2005;19(6):600-12.

  566. Lannin NA, Novak I, Cusick A. A systematic review of upper extremity casting for children and adults with central nervous system motor disorders. Clin Rehabil 2007;21(11):963-76.

  567. Mortenson PA, Eng JJ. The use of casts in the management of joint mobility and hypertonia following brain injury in adults: a systematic review. Phys Ther 2003;83(7):648-58.

  568. Sheffler LR, Hennessey MT, Naples GG, Chae J. Peroneal nerve stimulation versus an ankle foot orthosis for correction of footdrop in stroke: impact on functional ambulation. Neurorehabil Neural Repair 2006;20(3):355-60.

  569. de Wit DC, Buurke JH, Nijlant JM, Ijzerman MJ, Hermens HJ. The effect of an ankle-foot orthosis on walking ability in chronic stroke patients: a randomized controlled trial. Clin Rehabil 2004;18(5):550-7.

  570. Geboers JF, Drost MR, Spaans F, Kuipers H, Seelen HA. Immediate and long-term effects of ankle-foot orthosis on muscle activity during walking: a randomized study of patients with unilateral foot drop. Arch Phys Med Rehabil 2002;83(2):240-5.

  571. Kottink AI, Oostendorp LJ, Buurke JH, Nene AV, Hermens HJ, Ijzerman MJ. The orthotic effect of functional electrical stimulation on the improvement of walking in stroke patients with a dropped foot: a systematic review. Artif Organs 2004;28(6):577-86.

  572. Leijon G, Boivie J, Johansson I. Central smärta efter stroke ett förbryllande och bortglömt tillstånd. Läkartidningen 1990;87(5):294-300.

  573. Frese A, Husstedt IW, Ringelstein EB, Evers S. Pharmacologic treatment of central post-stroke pain. Clin J Pain 2006;22(3):252-60.

  574. Leijon G, Boivie J. Central post-stroke pain--the effect of high and low frequency TENS. Pain 1989;38(2):187-91.

  575. Leibovitz A, Baumoehl Y, Roginsky Y, Glick Z, Habot B, Segal R. Edema of the paretic hand in elderly post-stroke nursing patients. Arch Gerontol Geriatr 2007;44(1):37-42.

  576. Gokkaya NK, Aras M, Yesiltepe E, Koseoglu F. Reflex sympathetic dystrophy in hemiplegia. Int J Rehabil Res 2006;29(4):275-9.

  577. Gracies JM, Marosszeky JE, Renton R, Sandanam J, Gandevia SC, Burke D. Short-term effects of dynamic lycra splints on upper limb in hemiplegic patients. Arch Phys Med Rehabil 2000;81(12):1547-55.

  578. Faghri PD. The effects of neuromuscular stimulation-induced muscle contraction versus elevation on hand edema in CVA patients. J Hand Ther 1997;10(1):29-34.

  579. Roper TA, Redford S, Tallis RC. Intermittent compression for the treatment of the oedematous hand in hemiplegic stroke: a randomized controlled trial. Age Ageing 1999;28(1):9-13.

  580. Shumway-Cook A, Woollacott MH. Motor control: translating research into clinical practice. Philadelphia : Lippincott Williams & Wilkins; 2007.188

  581. Macko RF, Ivey FM, Forrester LW, Hanley D, Sorkin JD, Katzel LI, et al. Treadmill exercise rehabilitation improves ambulatory function and cardiovascular fitness in patients with chronic stroke: a randomized, controlled trial. Stroke 2005;36(10):2206-11.

  582. Engstad T, Viitanen M, Almkvist O. Kognitiv svikt etter hjerneslag-diagnostikk og håndtering. Tidsskr Nor Lægeforen 2007;127(10):1390-3.

  583. Richards LG, Latham NK, Jette DU, Rosenberg L, Smout RJ, DeJong G. Characterizing occupational therapy practice in stroke rehabilitation. Arch Phys Med Rehabil 2005;86(12 Suppl 2):S51-S60.

  584. Keren O, Motin M, Heinemann AW, O’Reilly CM, Bode RK, Semik P, et al. Relationship between rehabilitation therapies and outcome of stroke patients in Israel: a preliminary study. Isr Med Assoc J 2004;6(12):736-41.

  585. Duncan PW, Zorowitz R, Bates B, Choi JY, Glasberg JJ, Graham GD, et al. Management of Adult Stroke Rehabilitation Care: a clinical practice guideline. Stroke 2005;36(9):e100-e143.

  586. Lincoln NB, Majid MJ, Weyman N. Cognitive rehabilitation for attention deficits following stroke. Cochrane Database Syst Rev 2000;(4):CD002842.

  587. Cicerone KD, Dahlberg C, Malec JF, Langenbahn DM, Felicetti T, Kneipp S, et al. Evidence-based cognitive rehabilitation: updated review of the literature from 1998 through 2002. Arch Phys Med Rehabil 2005;86(8):1681-92.

  588. Majid MJ, Lincoln NB, Weyman N. Cognitive rehabilitation for memory deficits following stroke. Cochrane Database Syst Rev 2000;(3):CD002293.

  589. Wilson BA, Emslie HC, Quirk K, Evans JJ. Reducing everyday memory and planning problems by means of a paging system: a randomised control crossover study. J Neurol Neurosurg Psychiatry 2001;70(4):477-82.

  590. Luaute J, Halligan P, Rode G, Rossetti Y, Boisson D. Visuo-spatial neglect: a systematic review of current interventions and their effectiveness. Neurosci Biobehav Rev 2006;30(7):961-82.

  591. Bowen A, Lincoln NB, Dewey M. Cognitive rehabilitation for spatial neglect following stroke. Cochrane Database Syst Rev 2002;(2):CD003586.

  592. Edmans JA, Webster J, Lincoln NB. A comparison of two approaches in the treatment of perceptual problems after stroke. Clin Rehabil 2000;14(3):230-43.

  593. Robertson IH, McMillan TM, MacLeod E, Edgeworth J, Brock D. Rehabilitation by limb activation training reduces left-sided motor impairment in unilateral neglect patients: A single-blind randomised control trial. Neuropsychol Rehabil 2002;12(5):439-54.

  594. Donkervoort M, Dekker J, Stehmann-Saris FC, Deelman BG. Efficacy of strategy training in left hemisphere stroke patients with apraxia: a randomised clinical trial. NeuropsycholRehabil 2001;11(5):549-66.

  595. West C, Bowen A, Hesketh A, Vail A. Interventions for motor apraxia following stroke. Cochrane Database Syst Rev 2008;(1):CD004132.

  596. Johansson BB. Brain plasticity in health and disease. Keio J Med 2004;53(4):231-46.

  597. Wilhelmsen GB. Å se er ikke alltid nok: synsforstyrrelser etter hjerneskader og mulige tiltak. Oslo: Unipub; 2003.

  598. Greener J, Enderby P, Whurr R. Speech and language therapy for aphasia following stroke. Cochrane Database Syst Rev 1999;(2):CD000425.

  599. Bhogal SK, Teasell R, Speechley M. Intensity of aphasia therapy, impact on recovery. Stroke 2003;34(4):987-93.

  600. Moss A, Nicholas M. Language rehabilitation in chronic aphasia and time postonset: a review of single-subject data. Stroke 2006;37(12):3043-51.

  601. Doesborgh SJ, van de Sandt-Koenderman MW, Dippel DW, van Harskamp F, Koudstaal PJ, Visch-Brink EG. Effects of semantic treatment on verbal communication and linguistic processing in aphasia after stroke: a randomized controlled trial. Stroke 2004;35(1):141-6.

  602. Daniels SK, Stach CB, Maher LM. Evidence-based treatment outcomes in aphasia. Veterans Affairs Field Advisory Council; 2001.

  603. Nettleton J, Lesser R. Therapy for naming difficulties in aphasia : application of a cognitive neuropsychological model. J Neurolinguistics 1991;6(2):139-57.

  604. Pulvermuller F, Neininger B, Elbert T, Mohr B, Rockstroh B, Koebbel P, et al. Constraint-induced therapy of chronic aphasia after stroke. Stroke 2001;32(7):1621-6.

  605. Meinzer M, Djundja D, Barthel G, Elbert T, Rockstroh B. Long-term stability of improved language functions in chronic aphasia after constraint-induced aphasia therapy. Stroke 2005;36(7):1462-6.

  606. Katz RC, Wertz RT. The efficacy of computer-provided reading treatment for chronic aphasic adults. J Speech Lang Hear Res 1997;40(3):493-507.

  607. Kagan A, Black SE, Duchan FJ, Simmons-Mackie N, Square P. Training volunteers as conversation partners using “Supported Conversation for Adults with Aphasia” (SCA): a controlled trial. J Speech Lang Hear Res 2001;44(3):624-38.

  608. Elman RJ, Bernstein-Ellis E. The efficacy of group communication treatment in adults with chronic aphasia. J Speech Lang Hear Res 1999;42(2):411-9.

  609. West C, Hesketh A, Vail A, Bowen A. Interventions for apraxia of speech following stroke. Cochrane Database Syst Rev 2005;(4):CD004298.

  610. Wambaugh JL, Doyle PJ. Treatment for acquired apraxia of speech: a review of efficacy reports. Clin Aphasiol 1994;22:231-43.

  611. Wambaugh JL, Kalinyak-Fliszar MM, West JE, Doyle PJ. Effects of treatment for sound errors in apraxia of speech and aphasia. J Speech Lang Hear Res 1998;41(4):725-43.

  612. Freed DB, Marshall RC, Frazier KE. Long-term effectiveness of PROMPT treatment in a severely apractic-aphasic speaker. Aphasiology 1997;11(4-5):365-72.

  613. Bose A, Square PA, Schlosser R, van Lieshout P. Effects of PROMPT therapy on speech motor function in a person with aphasia and apraxia of speech. Aphasiology 2001;15(8):767-85.

  614. Apel K, Bartolotta TE, Brickell AA, Hewitt LE, Kummer AW, et al. Scope of Practice in Speech-Language Pathology [nettdokument]. Rockville, MD: American Speech-Language-Hearing Association (ASHA) [oppdatert 2009]. Tilgjengelig fra: www.asha.org/docs/html/SP2007-00283.html

  615. International association of logopedics and phoniatrics [nettside]. [oppdatert 2010] Tilgjengelig fra: ialp.info/joomla/

  616. Speech-language treatment/instruction/early intervention, preferred practice patterns for the profession of speech-language pathology. ASHA desk reference. I: ASHA desk reference. Rockville (MD): American Speech-Language-Hearing Association (ASHA); 2002. s. 160-2.

  617. Sellars C, Hughes T, Langhorne P. Speech and language therapy for dysarthria due to non-progressive brain damage. Cochrane Database Syst Rev 2005;(3):CD002088.

  618. McCaffrey P. The Neuroscience on the Web Series: CMSD 642 Neuropathologies of Swallowing and Speech [nettside]. Chico, CA: California State University [oppdatert 2008; lest 2009]. Tilgjengelig fra: www.csuchico.edu/~pmccaffrey/syllabi/SPPA342/index.html

  619. Helm-Estabrooks N, Yorkston KM, Spencer KA, Duffy JR. Behavioral management of respiratory/phonatory dysfunction from dysarthria: a systematic review of the evidence [nettdokument]. J Med Speech Lang Pathol [oppdatert 2003; lest 11 mar 2009]. Tilgjengelig fra: goliath.ecnext.com/coms2/summary_0199-2858315_ITM190

  620. Simpson MB, Till JA, Goff AM. Long-term treatment of severe dysarthria: a case study. J Speech Hear Disord 1988;53(4):433-40.

  621. Lukasik ML. AAC for Persons with Dysarthria and Apraxia. Michigan state university; 2005.

  622. Kane J. Poetry as right-hemispheric PsyArt: A Hyperlink Journal for the Psychological Study of the Arts, article 070205. Tilgjengelig fra: www.clas.ufl.edu/ipsa/journal/2007_kane01.shtml

  623. Rehabilitation institute of Chicago - Speech language pathology practice council. Cognitive communication disorders resulting from right hemisphere damage [nettdokument]. Chicago: Rehabilitation Institute of Chicago [oppdatert des 2007; lest mar 2009]. Tilgjengelig fra: life.geekpak.com/index.php?tray=content&tid=top122&cid=282

  624. Bryan K. The right hemisphere language battery. London: Whurr Publishers; 1994.

  625. Ramsey DJ, Smithard DG, Kalra L. Early assessments of dysphagia and aspiration risk in acute stroke patients. Stroke 2003;34(5):1252-7.

  626. Milne AC, Avenell A, Potter J. Meta-analysis: protein and energy supplementation in older people. Ann Intern Med 2006;144(1):37-48.

  627. Poor nutritional status on admission predicts poor outcomes after stroke: observational data from the FOOD trial. Stroke 2003;34(6):1450-6.

  628. Davis JP, Wong AA, Schluter PJ, Henderson RD, O’Sullivan JD, Read SJ. Impact of premorbid undernutrition on outcome in stroke patients. Stroke 2004;35(8):1930-4.

  629. Gariballa SE. Malnutrition in hospitalized elderly patients: when does it matter? Clin Nutr 2001;20(6):487-91.

  630. Dennis MS, Lewis SC, Warlow C. Routine oral nutritional supplementation for stroke patients in hospital (FOOD): a multicentre randomised controlled trial. Lancet 2005;365(9461):755-63.

  631. Stratton RJ, Green CJ, Elia M. Disease-related malnutrition: an evidence-based approach to treatment. Wallingford: CABI; 2003.

  632. Milne AC, Potter J, Avenell A. Protein and energy supplementation in elderly people at risk from malnutrition. Cochrane Database Syst Rev 2005;(2):CD003288.

  633. Nasjonale faglige retningslinjer for forebygging og behandling av underernæring. Oslo: Helsedirektoratet; 2009. Tilgjengelig fra: www.helsedirektoratet.no/vp/multimedia/archive/00277/Nasjonale_faglige_r_277739a.PDF

  634. Koretz RL, Avenell A, Lipman TO, Braunschweig CL, Milne AC. Does enteral nutrition affect clinical outcome? A systematic review of the randomized trials. Am J Gastroenterol 2007;102(2):412-29.

  635. Fure B. Depresjon, angst og andre emosjonelle symptomer ved hjerneslag. Tidsskr Nor Lægeforen 2007;127(10):1387-9.

  636. Anderson CS, Hackett ML, House AO. Interventions for preventing depression after stroke. Cochrane Database Syst Rev 2004;(2):CD003689.

  637. Hackett ML, Anderson CS, House AO. Interventions for treating depression after stroke. Cochrane Database Syst Rev 2004;(3):CD003437.

  638. Williams LS, Kroenke K, Bakas T, Plue LD, Brizendine E, Tu W, et al. Care management of poststroke depression: a randomized, controlled trial. Stroke 2007;38(3):998-1003.

  639. House AO, Hackett ML, Anderson CS, Horrocks JA. Pharmaceutical interventions for emotionalism after stroke. Cochrane Database Syst Rev 2004;(2):CD003690.

  640. Brittain KR, Peet SM, Castleden CM. Stroke and incontinence. Stroke 1998;29(2):524-8.

  641. Thomas LH, Barrett J, Cross S, French B, Leathley M, Sutton C, et al. Prevention and treatment of urinary incontinence after stroke in adults. Cochrane Database Syst Rev 2005;(3):CD004462.

  642. Pettersen R, Wyller TB. Prognostic significance of micturition disturbances after acute stroke. J Am Geriatr Soc 2006;54(12):1878-84.

  643. Pettersen R. Inkontinens etter hjerneslag. Tidsskr Nor Lægeforen 2007;127(10):1383-6.

  644. Tibaek S, Gard G, Jensen R. Pelvic floor muscle training is effective in women with urinary incontinence after stroke: a randomised, controlled and blinded study. Neurourol Urodyn 2005;24(4):348-57.

  645. Tibaek S, Gard G, Jensen R. Is there a long-lasting effect of pelvic floor muscle training in women with urinary incontinence after ischemic stroke? A 6-month follow-up study. Int Urogynecol J Pelvic Floor Dysfunct 2007;18(3):281-7.

  646. Wikander B, Ekelund P, Milsom I. An evaluation of multidisciplinary intervention governed by functional independence measure (FIMSM) in incontinent stroke patients. Scand J Rehabil Med 1998;30(1):15-21.

  647. Langhammer B, Stanghelle JK. Bobath or motor relearning programme? A comparison of two different approaches of physiotherapy in stroke rehabilitation; a randomized controlled study. Clin Rehabil 2000;14(4):361-9.

  648. Vinsnes AG. Urininkontinens. Oslo: Akribe; 2005.

  649. Niel-Weise BS, van den Broek PJ. Urinary catheter policies for short-term bladder drainage in adults. Cochrane Database Syst Rev 2005;(3):CD004203.

  650. Dumoulin C, Korner-Bitensky N, Tannenbaum C. Urinary incontinence after stroke: identification, assessment, and intervention by rehabilitation professionals in Canada. Stroke 2007;38(10):2745-51.

  651. Dumoulin C, Korner-Bitensky N, Tannenbaum C. Urinary incontinence after stroke: does rehabilitation make a difference? A systematic review of the effectiveness of behavioral therapy. Top Stroke Rehabil 2005;12(3):66-76.

  652. Harari D, Norton C, Lockwood L, Swift C. Treatment of constipation and fecal incontinence in stroke patients: randomized controlled trial. Stroke 2004;35(11):2549-55.

  653. Harari D, Coshall C, Rudd AG, Wolfe CD. New-onset fecal incontinence after stroke: prevalence, natural history, risk factors, and impact. Stroke 2003;34(1):144-50.

  654. Quander CR, Morris MC, Melson J, Bienias JL, Evans DA. Prevalence of and factors associated with fecal incontinence in a large community study of older individuals. Am J Gastroenterol 2005;100(4):905-9.

  655. Brittain K, Perry S, Shaw C, Matthews R, Jagger C, Potter J. Isolated urinary, fecal, and double incontinence: Prevalence and degree of soiling in stroke survivors. J Am Geriatr Soc 2006;54(12):1915-9.

  656. Shephard RJ, Bouchard C. Principal components of fitness: relationship to physical activity and lifestyle. Can J Appl Physiol 1994;19(2):200-14.

  657. Carr JH, Shepherd RB. Stroke rehabilitation: guidelines for exercise and training to optimize motor skills. Edinburgh: Butterworth Heinemann; 2003.

  658. Hu G, Sarti C, Jousilahti P, Silventoinen K, Barengo NC, Tuomilehto J. Leisure time, occupational, and commuting physical activity and the risk of stroke. Stroke 2005;36(9):1994-9.

  659. Myint PK, Surtees PG, Wainwright NW, Luben RN, Welch AA, Bingham SA, et al. Physical health-related quality of life predicts stroke in the EPIC-Norfolk. Neurology 2007;69(24):2243-8.

  660. Hillsdon M, Foster C, Thorogood M. Interventions for promoting physical activity. Cochrane Database Syst Rev 2005;(1):CD003180.

  661. Steultjens EM, Dekker J, Bouter LM, van de Nes JC, Cup EH, van den Ende CH. Occupational therapy for stroke patients: a systematic review. Stroke 2003;34(3):676-87.192

  662. Logan PA, Gladman JR, Avery A, Walker MF, Dyas J, Groom L. Randomised controlled trial of an occupational therapy intervention to increase outdoor mobility after stroke. BMJ 2004;329(7479):1372-5.

  663. Thesen J, Malterud K. «Empowerment» og pasientstyrking – et undervisningsopplegg. Tidsskr Nor Lægeforen 2001;121(13):1624-8.

  664. Antonovsky A. Helbredets mysterium: at tåle stress og forblive rask. København: Hans Reitzel Forlag; 2000.

  665. Donnellan C, Hevey D, Hickey A, O’Neill D. Defining and quantifying coping strategies after stroke: a review. J Neurol Neurosurg Psychiatry 2006;77(11):1208-18.

  666. Smith J, Forster A, House A, Knapp P, Wright J, Young J. Information provision for stroke patients and their caregivers. Cochrane Database Syst Rev 2008;(2):CD001919.

  667. Watkins CL, Auton MF, Deans CF, Dickinson HA, Jack CI, Lightbody CE, et al. Motivational interviewing early after acute stroke: a randomized, controlled trial. Stroke 2007;38(3):1004-9.

  668. Darlington AS, Dippel DW, Ribbers GM, van Balen R, Passchier J, Busschbach JJ. Coping strategies as determinants of quality of life in stroke patients: a longitudinal study. Cerebrovasc Dis 2007;23(5-6):401-7.

  669. Desrosiers J, Noreau L, Rochette A, Carbonneau H, Fontaine L, Viscogliosi C, et al. Effect of a home leisure education program after stroke: a randomized controlled trial. Arch Phys Med Rehabil 2007;88(9):1095-100.

  670. Turner-Stokes L, Disler PB, Nair A, Wade DT. Multi-disciplinary rehabilitation for acquired brain injury in adults of working age. Cochrane Database Syst Rev 2005;(3):CD004170.

  671. Lov om helsepersonell m.v. (helsepersonelloven). LOV-1999-07-02-64.

  672. Sundet K, Goffeng L, Hofft E. To drive or not to drive: neuropsychological assessment for driver’s license among stroke patients. Scand J Psychol 1995;36(1):47-58.

  673. Mosberg A, Østen PE, Schanke A. Bilkjøring etter hjerneskade. Tidsskr Nor Lægeforen 2000;120(28):1349-52.

  674. Sørfonden WB, Dysvik E, Karlsen B. Gjengedal E, Hanestad BR, red. Å leve med kronisk sykdom: en varig kursendring. Oslo: Cappelen akademisk; 2007.

  675. Eilertsen G. “Alt er som før, men ingenting er som det var” : gamle kvinners opplevelser av livet etter hjerneslag [avhandling]. Oslo: Universitetet i Oslo, Det medisinske fakultet, Institutt for sykepleievitenskap og helsefag, Seksjon for sykepleievitenskap; Unipub; 2005.

  676. Rombough RE, Howse EL, Bagg SD, Bartfay WJ. A comparison of studies on the quality of life of primary caregivers of stroke survivors: a systematic review of the literature. Top Stroke Rehabil 2007;14(3):69-79.

  677. Clark MS, Rubenach S, Winsor A. A randomized controlled trial of an education and counselling intervention for families after stroke. Clin Rehabil 2003;17(7):703-12.

  678. Visser-Meily A, Post M, van dP, I, van Heugten C, van den BT. Psychosocial functioning of spouses in the chronic phase after stroke: improvement or deterioration between 1 and 3 years after stroke? Patient Educ Couns 2008;73(1):153-8.

  679. Korpelainen JT, Nieminen P, Myllyla VV. Sexual functioning among stroke patients and their spouses. Stroke 1999;30(4):715-9.

  680. Monga TN, Lawson JS, Inglis J. Sexual dysfunction in stroke patients. Arch Phys Med Rehabil 1986;67(1):19-22.

  681. Boldrini P, Basaglia N, Calanca MC. Sexual changes in hemiparetic patients. Arch Phys Med Rehabil 1991;72(3):202-7.

  682. Olsen BCR, Grefberg MO. Å være i samme båt... Likemannsarbeid i funksjonshemmedes organisasjoner. En veileder. Oslo: Sosial- og helsedepartementet; 1994. Tilgjengelig fra: www.regjeringen.no/

  683. Arbeids- og inkluderingsdepartementet. Resultater og erfaringer fra Regjeringens handlingsplaner for funksjonshemmede og veien videre. St.meld. nr. 34 (1996-97).

  684. Olsen BCR. Støtte blant sine egne... likemannsarbeid i funksjonshemmedes organisasjoner. Oslo: Høgskolen i Oslo; 1998. HiO-rapport 1998:1.

  685. Visser-Meily A, van Heugten C, Post M, Schepers V, Lindeman E. Intervention studies for caregivers of stroke survivors: a critical review. Patient Educ Couns 2005;56(3):257-67.

Vedlegg